200,000+ products from a single source!
sales@angenechem.com
Home > Fluorides > 138530-95-7
138530-95-7 | 1H-Benzimidazole, 2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-
CAS No: 138530-95-7 Catalog No: AG0019E4 MDL No:
Product Description
Catalog Number:
AG0019E4
Chemical Name:
1H-Benzimidazole, 2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-
CAS Number:
138530-95-7
Molecular Formula:
C16H14F3N3O2S
Molecular Weight:
369.3615
IUPAC Name:
2-[(S)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
InChI:
InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m0/s1
InChI Key:
MJIHNNLFOKEZEW-VWLOTQADSA-N
SMILES:
O=[S@](c1nc2c([nH]1)cccc2)Cc1nccc(c1C)OCC(F)(F)F
UNII:
FB55O16184
Properties
Complexity:
480
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
369.076g/mol
Formal Charge:
0
Heavy Atom Count:
25
Hydrogen Bond Acceptor Count:
8
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
369.362g/mol
Monoisotopic Mass:
369.076g/mol
Rotatable Bond Count:
5
Topological Polar Surface Area:
87.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.8
Literature
| Title | Journal |
|---|---|
| Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan. | British journal of clinical pharmacology 20121101 |
| Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance. | Journal of pediatric gastroenterology and nutrition 20121101 |
| Pharmacokinetics of lansoprazole and its main metabolites after single intravenous doses in healthy Chinese subjects. | Xenobiotica; the fate of foreign compounds in biological systems 20121101 |
| Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial. | Journal of gastroenterology and hepatology 20121101 |
| Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. | The Journal of pharmacology and experimental therapeutics 20121101 |
| Diagnosis of Zollinger-Ellison syndrome: increasingly difficult. | World journal of gastroenterology 20121021 |
| Lessons from two cases of anaphylaxis to proton pump inhibitors. | Journal of clinical pharmacy and therapeutics 20121001 |
| Pharmacogenomic/pharmacokinetic assessment of a four-probe cocktail for CYPs and OATPs following oral microdosing. | International journal of clinical pharmacology and therapeutics 20121001 |
| The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the 'gastric barrier effect' in patients chronically treated with PPI: a pilot study. | Journal of clinical gastroenterology 20121001 |
| A clinically significant interaction between tacrolimus and multiple proton pump inhibitors in a kidney transplant recipient. | Pediatric transplantation 20120901 |
| Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain. | Journal of gastroenterology and hepatology 20120901 |
| Acute appendicitis in a developing country. | World journal of surgery 20120901 |
| Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. | Drug metabolism and disposition: the biological fate of chemicals 20120901 |
| Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects. | The Journal of clinical endocrinology and metabolism 20120901 |
| Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome. | Pharmacotherapy 20120901 |
| Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy. | Journal of clinical biochemistry and nutrition 20120901 |
| Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. | Helicobacter 20120801 |
| Different effects of proton pump inhibitors and famotidine on the clopidogrel metabolic activation by recombinant CYP2B6, CYP2C19 and CYP3A4. | Xenobiotica; the fate of foreign compounds in biological systems 20120701 |
| Differential inhibitory effects of proton pump inhibitors on the metabolism and antiplatelet activities of clopidogrel and prasugrel. | Biopharmaceutics & drug disposition 20120701 |
| Trends of outpatient prescription drug utilization in US children, 2002-2010. | Pediatrics 20120701 |
| Lansoprazole of no benefit in children with asthma. | The Journal of pediatrics 20120701 |
| Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori. | Journal of clinical pharmacy and therapeutics 20120601 |
| Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients. | Pediatric blood & cancer 20120601 |
| Lansoprazole inhibits nitric oxide and prostaglandin E(2) production in murine macrophage RAW 264.7 cells. | Inflammation 20120601 |
| A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. | Rheumatology international 20120601 |
| A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease. | Digestive diseases and sciences 20120601 |
| Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data. | The European journal of health economics : HEPAC : health economics in prevention and care 20120601 |
| Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors. | Pharmacotherapy 20120601 |
| Comparison of rate of surgical wound infection, length of hospital stay and patient convenience in complicated appendicitis between primary closure and delayed primary closure. | JPMA. The Journal of the Pakistan Medical Association 20120601 |
| Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. | Heart (British Cardiac Society) 20120515 |
| Peripheral arterial disease of the lower extremities. | Archives of medical science : AMS 20120509 |
| N-substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases. | Amino acids 20120501 |
| Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood. | European journal of clinical pharmacology 20120501 |
| Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients. | The American journal of gastroenterology 20120501 |
| Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. | Journal of gastroenterology 20120501 |
| Absorption, distribution, metabolism and excretion of [14C]dexlansoprazole in healthy male subjects. | Clinical drug investigation 20120501 |
| Conservative long-term treatment of children with eosinophilic esophagitis. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20120501 |
| Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection. | Journal of mass spectrometry : JMS 20120501 |
| Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis. | Expert review of clinical pharmacology 20120501 |
| A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. | Journal of the American College of Cardiology 20120403 |
| Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole. | Molecular biology reports 20120401 |
| Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients. | Cancer chemotherapy and pharmacology 20120401 |
| Risk factors for laryngopharyngeal reflux. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20120401 |
| Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group. | Chirality 20120401 |
| Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection. | Helicobacter 20120401 |
| Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. | Journal of digestive diseases 20120401 |
| Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy. | Journal of gastroenterology and hepatology 20120401 |
| Asian consensus report on functional dyspepsia. | Journal of neurogastroenterology and motility 20120401 |
| Marine bioactives: pharmacological properties and potential applications against inflammatory diseases. | Marine drugs 20120401 |
| [Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study]. | Zhonghua yi xue za zhi 20120313 |
| Influence of different proton pump inhibitors on activity of cytochrome P450 assessed by [(13)C]-aminopyrine breath test. | Journal of clinical pharmacology 20120301 |
| Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide. | European journal of clinical pharmacology 20120301 |
| In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins. | Acta dermato-venereologica 20120301 |
| The safety of fetal exposure to proton-pump inhibitors during pregnancy. | Digestive diseases and sciences 20120301 |
| Acid suppression for reflux disease: 'off-the-peg' or a tailored approach? | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120301 |
| Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120301 |
| Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers. | The American journal of gastroenterology 20120301 |
| New gastroprotective labdeneamides from (4S,9R,10R) methyl 18-carboxy-labda-8,13(E)-diene-15-oate. | Planta medica 20120301 |
| Role of flexible transnasal esophagoscopy and patient education in the management of globus pharyngeus. | Journal of the Formosan Medical Association = Taiwan yi zhi 20120301 |
| Reducing co-administration of clopidogrel and proton pump inhibitors in acute coronary syndromes. | The journal of the Royal College of Physicians of Edinburgh 20120301 |
| Different gastoroesophageal reflux symptoms of middle-aged to elderly asthma and chronic obstructive pulmonary disease (COPD) patients. | Journal of clinical biochemistry and nutrition 20120301 |
| Anti-Helicobacter pylori effects of IgY from egg york of immunized hens. | Laboratory animal research 20120301 |
| Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. | World journal of gastrointestinal pharmacology and therapeutics 20120206 |
| Development and validation of a highly sensitive LC-MS/MS method for quantitation of dexlansoprazole in human plasma: application to a human pharmacokinetic study. | Biomedical chromatography : BMC 20120201 |
| Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study. | Digestive diseases and sciences 20120201 |
| Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas. | JRSM short reports 20120201 |
| Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. | JAMA 20120125 |
| Children, asthma, and proton pump inhibitors: costs and perils of therapeutic creep. | JAMA 20120125 |
| Tranexamic acid for upper gastrointestinal bleeding. | The Cochrane database of systematic reviews 20120118 |
| Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology. | Pharmaceutical development and technology 20120101 |
| Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea. | British journal of clinical pharmacology 20120101 |
| Pharmacokinetics and safety of dexlansoprazole MR in adolescents with symptomatic GERD. | Journal of pediatric gastroenterology and nutrition 20120101 |
| Freeze dried chitosan/ poly-(glutamic acid) microparticles for intestinal delivery of lansoprazole. | Current drug delivery 20120101 |
| Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. | European journal of dermatology : EJD 20120101 |
| Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor. | Scandinavian journal of gastroenterology 20120101 |
| Impact of acid inhibition on esophageal mucosal injury induced by low-dose aspirin. | Digestion 20120101 |
| Comparison of the effect of non-antifungal and antifungal agents on Candida isolates from the gastrointestinal tract. | Archives of Iranian medicine 20120101 |
| Impact of laparoscopic fundoplication for the treatment of laryngopharyngeal reflux: review of the literature. | International journal of otolaryngology 20120101 |
| Analysis of nonformulary use of PPIs and excess drug cost in a Veterans Affairs population. | Journal of managed care pharmacy : JMCP 20120101 |
| Roles of oxidative stress in stomach disorders. | Journal of clinical biochemistry and nutrition 20120101 |
| Effects of proton pump inhibitors on pediatric inflammatory esophagogastric polyps. | Digestion 20120101 |
| Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101 |
| Splenic rupture in a patient with pelvic abscess and sepsis. | Singapore medical journal 20120101 |
| Applicability of a short/rapid 13C-urea breath test for Helicobacter pylori: retrospective multicenter chart review study. | BMC gastroenterology 20120101 |
| Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: a randomized, open-labeled, two-way crossover study. | Medical science monitor : international medical journal of experimental and clinical research 20120101 |
| Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology. | Frontiers in pharmacology 20120101 |
| Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents. | Current medicinal chemistry 20120101 |
| African American patients with gout: efficacy and safety of febuxostat vs allopurinol. | BMC musculoskeletal disorders 20120101 |
| Recent advances in noncardiac chest pain in Korea. | Gut and liver 20120101 |
| Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study. | Gut and liver 20120101 |
| Non-steroidal anti-inflammatory drugs for the treatment of pain and immobility-associated osteoarthritis: consensus guidance for primary care. | BMC family practice 20120101 |
| The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age. | BMC geriatrics 20120101 |
| Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. | Clinical and experimental gastroenterology 20120101 |
| Increased levels of multiresistant bacteria and resistance genes after wastewater treatment and their dissemination into lake geneva, Switzerland. | Frontiers in microbiology 20120101 |
| A review of wearable sensors and systems with application in rehabilitation. | Journal of neuroengineering and rehabilitation 20120101 |
| Simultaneous acute appendicitis with right testicular torsion. | Journal of Indian Association of Pediatric Surgeons 20120101 |
| A survey of patient preferences for a placebo orodispersible tablet. | Patient preference and adherence 20120101 |
| Rescue Therapy for Helicobacter pylori Infection 2012. | Gastroenterology research and practice 20120101 |
| Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study. | Gastroenterology research and practice 20120101 |
| Mechanisms of Gastroprotective Effects of Ethanolic Leaf Extract of Jasminum sambac against HCl/Ethanol-Induced Gastric Mucosal Injury in Rats. | Evidence-based complementary and alternative medicine : eCAM 20120101 |
| A review of transbuccal fentanyl use in the emergency department. | Pain research and treatment 20120101 |
| The protective role of Aegle marmelos on aspirin-induced gastro-duodenal ulceration in albino rat model: a possible involvement of antioxidants. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101 |
| Efficacy of esomeprazole in treating acid-related diseases in Japanese populations. | Clinical and experimental gastroenterology 20120101 |
| Antioxidant action of mangrove polyphenols against gastric damage induced by absolute ethanol and ischemia-reperfusion in the rat. | TheScientificWorldJournal 20120101 |
| The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation. | International journal of hepatology 20120101 |
| Gastric diverticulum of the prepyloric region: a rare presentation of gastric diverticulum. | Case reports in gastroenterology 20120101 |
| Protein-losing enteropathy in ulcerative colitis. | Case reports in gastroenterology 20120101 |
| Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey. | Indian journal of dermatology 20120101 |
| [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors]. | Terapevticheskii arkhiv 20120101 |
| In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. | Digestion 20120101 |
| Late hypersensitivity to omeprazole and other proton pump inhibitors. | Acta clinica Belgica 20120101 |
| Possible involvement of host defense mechanism in the suppression of rat acute reflux esophagitis by the particular histamine H2 receptor antagonist lafutidine. | Pharmacology 20120101 |
| Microscopic colitis - a missed diagnosis in diarrhea-predominant irritable bowel syndrome. | Maedica 20120101 |
| Antiprotozoal activity of proton-pump inhibitors. | Bioorganic & medicinal chemistry letters 20111215 |
| Time to stop blaming gastroesophageal reflux. | Clinical pediatrics 20111201 |
| Understanding atmospheric organic aerosols via factor analysis of aerosol mass spectrometry: a review. | Analytical and bioanalytical chemistry 20111201 |
| Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: a multicenter prospective observational study. | Journal of Korean medical science 20111201 |
| Medical reversal: why we must raise the bar before adopting new technologies. | The Yale journal of biology and medicine 20111201 |
| Treatment for Eradication of Helicobacter pylori Infection among Chronic Hepatitis C Patients. | Gut and liver 20111201 |
| Failure of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of H. pylori Eradication in H. pylori-Infected Patients with Functional Dyspepsia. | Gut and liver 20111201 |
| Recovering protein-protein and domain-domain interactions from aggregation of IP-MS proteomics of coregulator complexes. | PLoS computational biology 20111201 |
| Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. | Gut 20111101 |
| Helicobacter pylori infection-related pancytopenia in a young boy. | Pediatric hematology and oncology 20111101 |
| Steroid Receptor RNA Activator bi-faceted genetic system: Heads or Tails? | Biochimie 20111101 |
| The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. | Drug metabolism and disposition: the biological fate of chemicals 20111101 |
| Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia. | Journal of gastroenterology 20111101 |
| Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data. | The American journal of gastroenterology 20111101 |
| Efficacy of vitamins supplementation to therapy on Helicobacter pylori eradication in patients with low antioxidant capacity. | Clinics and research in hepatology and gastroenterology 20111101 |
| A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. | The American journal of gastroenterology 20111101 |
| Quality evaluation of extemporaneous delayed-release liquid formulations of lansoprazole. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111101 |
| Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen. | The American journal of gastroenterology 20111101 |
| Black hairy tongue associated with erlotinib treatment in a patient with advanced lung cancer. | Annals of dermatology 20111101 |
| A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male. | Rare tumors 20111021 |
| Distinct colonoscopy findings of microscopic colitis: not so microscopic after all? | World journal of gastroenterology 20111007 |
| Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole. | Journal of clinical pharmacology 20111001 |
| Do the laryngopharyngeal symptoms and signs ameliorate by empiric treatment in patients with suspected laryngopharyngeal reflux? | Auris, nasus, larynx 20111001 |
| Gastroesophageal reflux disease at any cost: a dangerous paediatric attitude. | Acta paediatrica (Oslo, Norway : 1992) 20111001 |
| Anti-ulcerogenic effect of aqueous propolis extract and the influence of radiation exposure. | International journal of radiation biology 20111001 |
| Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. | Gastroenterology 20111001 |
| Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome. | Pharmacoepidemiology and drug safety 20111001 |
| Effect of fluoxetine on the pharmacokinetics of lansoprazole: a two-treatment period study in healthy male subjects. | Clinical drug investigation 20111001 |
| Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter. | The Journal of pharmacy and pharmacology 20111001 |
| Perforated dried blood spots: a novel format for accurate microsampling. | Bioanalysis 20111001 |
| Inhibitory and bactericidal potential of crude acetone extracts of Combretum molle (Combretaceae) on drug-resistant strains of Helicobacter pylori. | Journal of health, population, and nutrition 20111001 |
| Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease? | Journal of neurogastroenterology and motility 20111001 |
| Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. | Journal of neurogastroenterology and motility 20111001 |
| [Endotracheal tube cuff and nitrous oxide: bench evaluation and assessment of clinical practice]. | Annales francaises d'anesthesie et de reanimation 20110901 |
| Short-term healing process of artificial ulcers after gastric endoscopic submucosal dissection. | Gut and liver 20110901 |
| A multicenter, randomized, comparative study to determine the appropriate dose of lansoprazole for use in the diagnostic test for gastroesophageal reflux disease. | Gut and liver 20110901 |
| Topical steroids to treat granulomatous mastitis: a case report. | The Korean journal of internal medicine 20110901 |
| A case of follicular B-cell lymphoma treated using clarithromycin. | The Korean journal of hematology 20110901 |
| 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. | Lancet (London, England) 20110806 |
| Mass eradication of Helicobacter pylori: feasible and advisable? | Lancet (London, England) 20110806 |
| Dexlansoprazole MR: a review. | Annals of medicine 20110801 |
| Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura. | Journal of gastroenterology 20110801 |
| Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors. | Alimentary pharmacology & therapeutics 20110801 |
| Dexlansoprazole MR for the management of gastroesophageal reflux disease. | Expert review of gastroenterology & hepatology 20110801 |
| Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations. | Clinical therapeutics 20110801 |
| Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol. | Journal of Korean medical science 20110801 |
| Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer. | Southern medical journal 20110801 |
| Acute abdomen caused by both acute appendicitis and epididymitis. | The journal of medical investigation : JMI 20110801 |
| Gastroprotective activity of epitaondiol and sargaol. | Natural product communications 20110801 |
| (R)-(+)-2-{[(3-Methyl-4-nitro-pyridin-2-yl)meth-yl]sulfin-yl}-1H-benzimidazole. | Acta crystallographica. Section E, Structure reports online 20110801 |
| Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma. | Journal of pharmaceutical and biomedical analysis 20110715 |
| Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers. | Journal of clinical pharmacology 20110701 |
| Recent developments in the treatment of osteoarthritis with NSAIDs. | Current medical research and opinion 20110701 |
| Does long-term aspirin use have any effect on Helicobacter pylori eradication? | The American journal of the medical sciences 20110701 |
| Lansoprazole inhibits mitochondrial superoxide production and cellular lipid peroxidation induced by indomethacin in RGM1 cells. | Journal of clinical biochemistry and nutrition 20110701 |
| Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time C Breath Test (BreathID System). | Journal of neurogastroenterology and motility 20110701 |
| Psychiatric Co-morbidity and Efficacy of Mirtazapine Treatment in Young Subjects With Chronic or Cyclic Vomiting Syndromes: A Case Series. | Journal of neurogastroenterology and motility 20110701 |
| Zollinger-Ellison syndrome: presentation, response to therapy, and outcome. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110601 |
| Gastroprotective effect and cytotoxicity of carnosic acid derivatives. | Planta medica 20110601 |
| Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans. | Drug metabolism and pharmacokinetics 20110601 |
| A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals. | The Journal of pharmacology and experimental therapeutics 20110601 |
| Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. | Journal of gastroenterology 20110601 |
| Effects of CYP2C19 polymorphism on the pharmacokinetics of lansoprazole and its main metabolites in healthy Chinese subjects. | Xenobiotica; the fate of foreign compounds in biological systems 20110601 |
| A new modified concomitant therapy for Helicobacter pylori eradication in Turkey. | Helicobacter 20110601 |
| Application of levofloxacine in the second phase of sequential therapy regimen for Helicobacter pylori eradication: is it a good choice? | Minerva medica 20110601 |
| Spontaneous bilateral distal ulna fracture: an unusual complication in a rheumatoid patient. | Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20110601 |
| Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial. | Journal of Korean medical science 20110601 |
| [Pharmacology of preventive and therapeutic drugs for NSAIDs ulcers in the gastrointestinal tract]. | Nihon rinsho. Japanese journal of clinical medicine 20110601 |
| [Points that should be considered for selecting drugs for the prevention and treatment of NSAIDs-related ulcers]. | Nihon rinsho. Japanese journal of clinical medicine 20110601 |
| Clinical Characteristics of Microscopic Colitis in Korea: Prospective Multicenter Study by KASID. | Gut and liver 20110601 |
| Direct injection of native aqueous matrices by achiral-chiral chromatography ion trap mass spectrometry for simultaneous quantification of pantoprazole and lansoprazole enantiomers fractions. | Journal of chromatography. A 20110520 |
| Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospecive case-series and systematic review of the literature. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110501 |
| Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation. | Coronary artery disease 20110501 |
| Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes. | Glia 20110501 |
| A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands. | Biochemical pharmacology 20110501 |
| Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment. | British journal of haematology 20110501 |
| Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. | Pediatrics 20110501 |
| Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem? | Scandinavian journal of gastroenterology 20110401 |
| BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy. | Gut 20110401 |
| Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. | Journal of medicinal food 20110401 |
| Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation. | Journal of clinical pharmacy and therapeutics 20110401 |
| Studies of distribution and recurrence of Helicobacter spp. gastric mucosa of dogs after triple therapy. | Acta cirurgica brasileira 20110401 |
| Effect of Lactobacillus acidophilus & epidermal growth factor on experimentally induced Clostridium difficile infection. | The Indian journal of medical research 20110401 |
| A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India. | Indian journal of pharmacology 20110401 |
| Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence. | Indian journal of pharmacology 20110401 |
| Noncardiac chest pain: epidemiology, natural course and pathogenesis. | Journal of neurogastroenterology and motility 20110401 |
| [Study on pharmacokinetics of lansoprozole in concentration of blood plasma healthy volunteers intravenous infusion by improved HPLC]. | Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20110401 |
| [Effect of jianpi yiqi qingyou decoction on lymphocyte subsets and IL-2 mRNA in gastric tissue in rats with chronic superficial gastritis]. | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20110401 |
| Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats. | Journal of ethnopharmacology 20110324 |
| Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301 |
| Gastroprotective effect and cytotoxicity of labdeneamides with amino acids. | Planta medica 20110301 |
| Presentation, response to lansoprazole therapy, and outcome of Zollinger-Ellison syndrome-like gastric acid hypersecretors. | Scandinavian journal of gastroenterology 20110301 |
| CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualization in H. pylori eradication. | European journal of clinical pharmacology 20110301 |
| Attenuation of stress-induced gastric lesions by lansoprazole, PD-136450 and ranitidine in rats. | Molecular and cellular biochemistry 20110301 |
| The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD. | The American journal of gastroenterology 20110301 |
| Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110301 |
| Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases. | Journal of clinical biochemistry and nutrition 20110301 |
| Different antiulcer activities of pantoprazole in stress, alcohol and pylorus ligation-induced ulcer models. | Laboratory animal research 20110301 |
| A new strategy of transforming pharmaceutical crystal forms. | Journal of the American Chemical Society 20110209 |
| Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups? | Journal of gastroenterology 20110201 |
| Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication. | Journal of gastroenterology 20110201 |
| The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20110201 |
| Comparison of two different treatment protocols in Helicobacter pylori eradication. | Southern medical journal 20110201 |
| Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy. | Current clinical pharmacology 20110201 |
| Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study. | Helicobacter 20110201 |
| Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. | Diabetes 20110201 |
| Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20110201 |
| Effect of esomeprazole on the pharmacokinetics of carbamazepine. | Indian journal of pharmacology 20110201 |
| 2-{[3-Methyl-4-(2,2,2-trifluoro-eth-oxy)pyridin-2-yl]methyl-sulfan-yl}-1H-benzimidazole monohydrate. | Acta crystallographica. Section E, Structure reports online 20110201 |
| Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H(+), K(+)-ATPase/H. pylori Inhibition and Anti-Oxidative Mechanism. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children. | Archives of disease in childhood 20110101 |
| Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms. | Pharmacological research 20110101 |
| Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101 |
| Individual metabolic capacity evaluation of cytochrome P450 2C19 by protein and activity in the small intestinal mucosa of Japanese pancreatoduodenectomy patients. | Biological & pharmaceutical bulletin 20110101 |
| Unusual cause of a painful right testicle in a 16-year-old man: a case report. | Journal of medical case reports 20110101 |
| Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial. | Digestion 20110101 |
| Transparent meta-analysis: does aging spare prospective memory with focal vs. non-focal cues? | PloS one 20110101 |
| Comprehensive small animal imaging strategies on a clinical 3 T dedicated head MR-scanner; adapted methods and sequence protocols in CNS pathologies. | PloS one 20110101 |
| Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain. | PloS one 20110101 |
| Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection. | Internal medicine (Tokyo, Japan) 20110101 |
| Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort. | PloS one 20110101 |
| Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma. | Journal of pain research 20110101 |
| Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. | PloS one 20110101 |
| [Prodrug technology in the development of medicinal agents]. | Duodecim; laaketieteellinen aikakauskirja 20110101 |
| [Modern approach to the prevention and treatment of NSAID-gastropathy]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. | BMJ (Clinical research ed.) 20110101 |
| Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. | BMC gastroenterology 20110101 |
| Nutritional management of Eosinophilic Gastroenteropathies: Case series from the community. | Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20110101 |
| Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. | PloS one 20110101 |
| Relative bioavailability of prasugrel free base in comparison to prasugrel hydrochloride in the presence and in the absence of a proton pump inhibitor. | Arzneimittel-Forschung 20110101 |
| Evaluating ranitidine, pantoprazole and placebo on gastric pH in elective surgery. | Saudi journal of anaesthesia 20110101 |
| Traditional Japanese Kampo Medicine: Clinical Research between Modernity and Traditional Medicine-The State of Research and Methodological Suggestions for the Future. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial. | Gastroenterology research and practice 20110101 |
| The prevalence of co-administration of clopidogrel and proton pump inhibitors. | Quality in primary care 20110101 |
| Signet Ring Cell Gastric Cancer Occurring after Radiation Therapy for Helicobacter pylori-Uninfected Mucosa-Associated Lymphoid Tissue Lymphoma. | Case reports in gastroenterology 20110101 |
| Compartmentalized Cerebral Metabolism of [1,6-(13)C]Glucose Determined by in vivo (13)C NMR Spectroscopy at 14.1 T. | Frontiers in neuroenergetics 20110101 |
| Laparoscopic versus open appendectomy: a comparison of primary outcome measures. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101 |
| Gastroesophageal reflux and idiopathic pulmonary fibrosis: a review. | Pulmonary medicine 20110101 |
| Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety. | Clinical interventions in aging 20110101 |
| Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease. | Drug, healthcare and patient safety 20110101 |
| Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry. | International journal of analytical chemistry 20110101 |
| Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. | BMC infectious diseases 20110101 |
| Wernicke's Encephalopathy in a Patient with Peptic Ulcer Disease. | Case reports in medicine 20110101 |
| Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori. | Case reports in gastroenterology 20110101 |
| Comparison of the effect of a single dose of erythromycin with pantoprazole on gastric content volume and acidity in elective general surgery patients. | Journal of anaesthesiology, clinical pharmacology 20110101 |
| Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs). | PloS one 20110101 |
| Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach. | Asian Pacific journal of cancer prevention : APJCP 20110101 |
| Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention. | Vascular health and risk management 20110101 |
| Gastroprotective Properties of Karanjin from Karanja (Pongamia pinnata) Seeds; Role as Antioxidant and H, K-ATPase Inhibitor. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| A biochemical study on the gastroprotective effect of hydroalcoholic extract of Andrographis paniculata in rats. | Indian journal of pharmacology 20110101 |
| Acute pancreatitis with saw palmetto use: a case report. | Journal of medical case reports 20110101 |
| Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori. | Scientia pharmaceutica 20110101 |
| Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety. | Journal of pharmacology & pharmacotherapeutics 20110101 |
| Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance. | Clinical proteomics 20110101 |
| Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey. | The Libyan journal of medicine 20110101 |
| Maternal anemia in rural jordan: room for improvement. | Anemia 20110101 |
| Thermal ablation for benign thyroid nodules: radiofrequency and laser. | Korean journal of radiology 20110101 |
| Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort. | PloS one 20110101 |
| Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication. | Hepato-gastroenterology 20110101 |
| Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey. | Health and quality of life outcomes 20110101 |
| Effects of proton pump inhibitors in patients with laryngopharyngeal reflux disease. | Hepato-gastroenterology 20110101 |
| The regenerating gene iα is overexpressed in atrophic gastritis rats with hypergastrinemia. | Gastroenterology research and practice 20110101 |
| Quality of online pharmacies and websites selling prescription drugs: a systematic review. | Journal of medical Internet research 20110101 |
| Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein. | PloS one 20110101 |
| Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg. | Clinical and experimental gastroenterology 20110101 |
| Aqueous and organic solvent-extracts of selected south African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: inhibitory and bactericidal potential. | International journal of molecular sciences 20110101 |
| Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension. | Pulmonary circulation 20110101 |
| Management and outcome of appendicitis among octogenarians in an English hospital over a five year period. | International journal of surgery (London, England) 20110101 |
| Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients. | Gastroenterology research and practice 20110101 |
| Use of a new ziprasidone-selective electrode in mixed solvents and its application in the analysis of pharmaceuticals and biological fluids. | Sensors (Basel, Switzerland) 20110101 |
| Gastroretentive microballoons of metformin: Formulation development and characterization. | Journal of advanced pharmaceutical technology & research 20110101 |
| Constructing a semantic predication gold standard from the biomedical literature. | BMC bioinformatics 20110101 |
| Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors. | Journal of translational medicine 20110101 |
| Effects of proton pump inhibitors and h(2) receptor antagonists on the ileum motility. | Gastroenterology research and practice 20110101 |
| Indigenous anti-ulcer activity of Musa sapientum on peptic ulcer. | Pharmacognosy research 20110101 |
| Use of superficial palmar arch for bridging the gap in digital revascularisation. | Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 20110101 |
| Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome. | Clinical pharmacology : advances and applications 20110101 |
| Influence of proton pump inhibitors on dexamethasone-induced gastric mucosal damage in rats. | Indian journal of pharmaceutical sciences 20110101 |
| Lansoprazole induces collagenous colitis in the colon of Mongolian gerbils. | Asian Pacific journal of cancer prevention : APJCP 20110101 |
| The comparative study of the effectiveness of cimetidine, ranitidine, famotidine, and omeprazole in treatment of children with dyspepsia. | ISRN pediatrics 20110101 |
| Two Cases of Helicobacter pylori-Negative Gastric Outlet Obstruction in Children. | Case reports in gastrointestinal medicine 20110101 |
| Novel approach to treatment of rectal mucosa-associated lymphoid tissue lymphoma. | BMJ case reports 20110101 |
| N-{N-[2-(3,5-Difluorophenyl)acetyl]-(S)-alanyl}-(S)-phenylglycine tert-butyl ester (DAPT): an inhibitor of γ-secretase, revealing fine electronic and hydrogen-bonding features. | Acta crystallographica. Section C, Crystal structure communications 20101215 |
| Management of recurrence of symptoms of gastroesophageal reflux disease: synergistic effect of rebamipide with 15 mg lansoprazole. | Digestive diseases and sciences 20101201 |
| Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse. | Digestive diseases and sciences 20101201 |
| Proton pump inhibitor therapy improves symptoms in postnasal drainage. | Gastroenterology 20101201 |
| Novel approaches to inhibition of gastric acid secretion. | Current gastroenterology reports 20101201 |
| Anatomy of the distal tibiofibular syndesmosis in adults: a pictorial essay with a multimodality approach. | Journal of anatomy 20101201 |
| Should fundoplication be added at the time of gastrostomy placement in patients who are neurologically impaired? | Journal of pediatric surgery 20101201 |
| The serotonin syndrome-the need for physician's awareness. | International journal of emergency medicine 20101201 |
| Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy. | World journal of gastroenterology 20101114 |
| The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests. | Journal of cardiovascular pharmacology 20101101 |
| Allergic angina can be determined by the early use of cardiac magnetic resonance imaging. | The American journal of emergency medicine 20101101 |
| The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial. | The American journal of gastroenterology 20101101 |
| Globus pharyngeus and extraesophageal reflux: simultaneous pH <4.0 and pH <5.0 analysis. | The Laryngoscope 20101101 |
| Safety profile of six months lansoprozole treatment in children. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20101101 |
| Synthesis, gastroprotective effect and cytotoxicity of new amino acid diterpene monoamides and diamides. | Molecules (Basel, Switzerland) 20101021 |
| Liquid chromatographic resolution of proton pump inhibitors including omeprazole on a ligand exchange chiral stationary phase. | Journal of chromatography. A 20101008 |
| Clinical practice. Protein-losing enteropathy in children. | European journal of pediatrics 20101001 |
| Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes. | Diabetologia 20101001 |
| Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. | Neurocritical care 20101001 |
| 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases. | The Journal of pharmacology and experimental therapeutics 20101001 |
| Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy. | Alimentary pharmacology & therapeutics 20101001 |
| Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20101001 |
| Short-term therapy with celecoxib and lansoprazole modulates Th1/ Th2 immune response in human gastric mucosa. | Helicobacter 20101001 |
| Partial regression of duodenal lesions of intestinal follicular lymphoma after antibiotic treatment. | Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 20101001 |
| Inappropriate Use of Intravenous PPI for Stress Ulcer Prophylaxis in an Inner City Community Hospital. | Journal of clinical medicine research 20101001 |
| The multi-systemic nature of diabetes mellitus: Genotype or phenotype? | North American journal of medical sciences 20101001 |
| Liquid chromatography/tandem mass spectrometry sensitivity enhancement via online sample dilution and trapping: applications in microdosing and dried blood spot (DBS) bioanalysis. | Rapid communications in mass spectrometry : RCM 20100915 |
| Age-dependent eradication of Helicobacter pylori in Japanese patients. | World journal of gastroenterology 20100907 |
| Protein-losing enteropathy associated with Henoch-Schönlein purpura. | Pediatric reports 20100906 |
| Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. | Journal of gastrointestinal cancer 20100901 |
| Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration. | Xenobiotica; the fate of foreign compounds in biological systems 20100901 |
| Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes. | British journal of clinical pharmacology 20100901 |
| Influences of sodium carbonate on physicochemical properties of lansoprazole in designed multiple coating pellets. | AAPS PharmSciTech 20100901 |
| [Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20100901 |
| Late-onset hypertrophic pyloric stenosis: definition of diagnostic criteria and algorithm for the management. | Journal of pediatric surgery 20100901 |
| Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors. | Anticancer research 20100901 |
| Dexlansoprazole modified release: in erosive oesophagitis and non-erosive reflux disease. | Drugs 20100820 |
| Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100801 |
| Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer. | Journal of gastroenterology 20100801 |
| Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. | Gastroenterology 20100801 |
| Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis. | British journal of clinical pharmacology 20100801 |
| The effect of CYP2C19 activity on pharmacokinetics of lansoprazole and its active metabolites in healthy subjects. | Pharmaceutical biology 20100801 |
| The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels. | Clinics (Sao Paulo, Brazil) 20100801 |
| Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system. | Clinical therapeutics 20100801 |
| Correlation between R/S enantiomer ratio of lansoprazole and CYP2C19 activity after single oral and enteral administration. | Chirality 20100701 |
| Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats. | Clinical and experimental pharmacology & physiology 20100701 |
| How to manage Helicobacter pylori after sequential therapy failure? | Journal of clinical gastroenterology 20100701 |
| Changes of gastric histology in patients with erosive oesophagitis receiving long-term lansoprazole maintenance therapy. | Alimentary pharmacology & therapeutics 20100701 |
| A majority of tube-fed patients are on medications that require special precautions. | Age and ageing 20100701 |
| Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - comparator study of esomeprazole, lansoprazole and pantoprazole. | Alimentary pharmacology & therapeutics 20100701 |
| Clinical trial: chest pain caused by presumed gastro-oesophageal reflux in coronary artery disease - controlled study of lansoprazole vs. placebo. | Alimentary pharmacology & therapeutics 20100701 |
| Drug interaction between itraconazole and bortezomib: exacerbation of peripheral neuropathy and thrombocytopenia induced by bortezomib. | Pharmacotherapy 20100701 |
| Asymptomatic Meckel's diverticulum in adults: is diverticulectomy indicated? | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100701 |
| Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100701 |
| Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin. | Journal of clinical biochemistry and nutrition 20100701 |
| Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship? | Journal of neurogastroenterology and motility 20100701 |
| Comparison of Direct Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease in Korean Tertiary Medical Center. | Journal of neurogastroenterology and motility 20100701 |
| Noncardiac chest pain in young patients. | Journal of neurogastroenterology and motility 20100701 |
| Update on antithrombotic therapy for stroke prevention in atrial fibrillation. | Current treatment options in cardiovascular medicine 20100601 |
| The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole. | Gut and liver 20100601 |
| Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100601 |
| Determination of the antiulcer properties of sodium cromoglycate in pylorus-ligated albino rats. | Indian journal of pharmacology 20100601 |
| Bis(2-{[3-methyl-4-(2,2,2-trifluoro-eth-oxy)-2-pyrid-yl]methyl-sulfan-yl}-1H,3H-benzimidazolium) 2,5-dichloro-3,6-dioxocyclo-hexa-1,4-diene-1,4-diolate. | Acta crystallographica. Section E, Structure reports online 20100601 |
| Safety of the long-term use of proton pump inhibitors. | World journal of gastroenterology 20100521 |
| Proton pump inhibitor administration via nasogastric tube in pediatric practice: comparative analysis with protocol optimization. | International journal of pharmaceutics 20100510 |
| Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole. | Digestive diseases and sciences 20100501 |
| Gastro-protective strategies in primary care in Italy: the 'Gas.Pro.' survey. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100501 |
| Ten-day sequential therapy of Helicobacter pylori infection in Thailand. | The American journal of gastroenterology 20100501 |
| Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist. | Biochemical pharmacology 20100501 |
| Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. | European journal of gastroenterology & hepatology 20100501 |
| Diagnostic value of the PPI test for detection of GERD in Korean patients and factors associated with PPI responsiveness. | Scandinavian journal of gastroenterology 20100501 |
| The effect of time-of-day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR: evidence for dosing flexibility with a Dual Delayed Release proton pump inhibitor. | Alimentary pharmacology & therapeutics 20100501 |
| Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20100501 |
| Dexlansoprazole in the treatment of esophagitis and gastroesophageal reflux disease. | The Annals of pharmacotherapy 20100501 |
| Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. | Gut 20100501 |
| Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. | Postgraduate medical journal 20100501 |
| The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan. | Methods and findings in experimental and clinical pharmacology 20100501 |
| Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100401 |
| Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick. | Bone 20100401 |
| Suppression of phosphorylation of extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase in polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100401 |
| Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors. | Alimentary pharmacology & therapeutics 20100401 |
| Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study. | Journal of Korean medical science 20100401 |
| Clinical distinct features of noncardiac chest pain in young patients. | Journal of neurogastroenterology and motility 20100401 |
| Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients. | Journal of clinical gastroenterology 20100301 |
| Inappropriate use of proton pump inhibitors. | Irish journal of medical science 20100301 |
| Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects. | Journal of thrombosis and haemostasis : JTH 20100301 |
| A bio-analytical hydrophilic interaction LC-MS/MS method for the simultaneous quantification of omeprazole and lansoprazole in human plasma in support of a pharmacokinetic omeprazole study in children. | Journal of separation science 20100301 |
| Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease. | The Annals of pharmacotherapy 20100301 |
| Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100301 |
| Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100301 |
| Hypothesis testing for the validation of the kinetic spectrophotometric methods for the determination of lansoprazole in bulk and drug formulations via Fe(III) and Zn(II) chelates. | Drug testing and analysis 20100301 |
| GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care setting. | Digestive diseases and sciences 20100201 |
| Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies. | Drug development and industrial pharmacy 20100201 |
| [Clinical analysis of recurrence rate and symptom improvement in gastro-esophageal reflux disease patients]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100201 |
| Dexlansoprazole for the treatment of esophagitis and GERD. | Drugs of today (Barcelona, Spain : 1998) 20100201 |
| Generics offer pharmacy plans specific benefits. | Managed care (Langhorne, Pa.) 20100201 |
| Effect of pantoprazole and its interactions with vecuronium on the neuromuscular junction. | Indian journal of pharmacology 20100201 |
| [Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study]. | Zhonghua yi xue za zhi 20100112 |
| Two-dimensional chromatography method applied to the enantiomeric determination of lansoprazole in human plasma by direct sample injection. | Chirality 20100101 |
| QTL analysis of early stage heterosis for biomass in Arabidopsis. | TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik 20100101 |
| Costs and risks in the management of patients with gastric acid hypersecretion. | Journal of clinical gastroenterology 20100101 |
| Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation. | Drug development and industrial pharmacy 20100101 |
| Modified Lanz incision in appendicectomy - the surgical trainees best friend. | International journal of surgery (London, England) 20100101 |
| Pediatric specialists' beliefs about gastroesophageal reflux disease in premature infants. | Pediatrics 20100101 |
| Linear mucosal defects: a characteristic endoscopic finding of lansoprazole-associated collagenous colitis. | Endoscopy 20100101 |
| Does pretreatment with lansoprazole influence Helicobacter pylori eradication rate and quality of life? | Digestion 20100101 |
| Patient self-treatment using lansoprazole for frequent nighttime heartburn. Commentary. | Postgraduate medicine 20100101 |
| Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. | Journal of Alzheimer's disease : JAD 20100101 |
| Gastroesophageal reflux symptoms in infants in a rural population: longitudinal data over the first six months. | BMC pediatrics 20100101 |
| Case report of recurrent acute appendicitis in a residual tip. | Cases journal 20100101 |
| Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. | Annals of general psychiatry 20100101 |
| Modern role for clopidogrel in management of atrial fibrillation and stroke reduction. | Vascular health and risk management 20100101 |
| Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol. | Therapeutics and clinical risk management 20100101 |
| Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. | Trials 20100101 |
| The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. | Arthritis research & therapy 20100101 |
| Toll-like receptor 4 modulation as a strategy to treat sepsis. | Mediators of inflammation 20100101 |
| Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial. | Annals of clinical microbiology and antimicrobials 20100101 |
| [Case of suspicious lansoprazole-associated collagenous colitis in ANCA-associated nephritis]. | Nihon Jinzo Gakkai shi 20100101 |
| Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany. | European journal of medical research 20100101 |
| Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101 |
| [How to choose correct proton pump inhibitors to patients with GERD?]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| Recurrent, robust and scalable patterns underlie human approach and avoidance. | PloS one 20100101 |
| Short segment hiatal hernia - the long and the short of it. | Journal of neurogastroenterology and motility 20100101 |
| Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor. | Vascular health and risk management 20100101 |
| Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study. | BMC pediatrics 20100101 |
| Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution? | European journal of medical research 20100101 |
| Abnormal macrophage response to microbial stimulus in a 43-year-old man with a severe form of atherosclerosis: a case report. | Journal of medical case reports 20100101 |
| NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease. | Frontiers in aging neuroscience 20100101 |
| Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients. | Therapeutics and clinical risk management 20100101 |
| Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction. | Therapeutics and clinical risk management 20100101 |
| Pharmacotherapy and the risk for community-acquired pneumonia. | BMC geriatrics 20100101 |
| Influence of cyclodextrin complexation with NSAIDs on NSAID/cold stress-induced gastric ulceration in rats. | International journal of medical sciences 20100101 |
| Multiple congenital red-brown macules, thrombocytopenia, and gastrointestinal bleeding. Diagnosis: Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). | Pediatric dermatology 20100101 |
| Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc. | Hepato-gastroenterology 20100101 |
| Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. | Annals of clinical microbiology and antimicrobials 20100101 |
| Long term changes in platelet counts after H. pylori eradication in non-ITP patients. | Platelets 20100101 |
| Autoimmune hepatitis triggered by nitrofurantoin: a case series. | Journal of medical case reports 20100101 |
| We should care more about intracuff pressure: The actual situation in government sector teaching hospital. | Indian journal of anaesthesia 20100101 |
| Anti-Ro and anti-La antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole. | European journal of dermatology : EJD 20100101 |
| [Lanzoptol efficacy at gastroesophageal reflux disease: results of multicenter study leader]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| Gastric emptying and electrogastrography in reflux esophagitis: results in patients showing endoscopically erosive esophagitis under proton pump inhibitor therapy. | Hepato-gastroenterology 20100101 |
| Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole. | Therapeutics and clinical risk management 20100101 |
| Distribution analysis of hydrogenases in surface waters of marine and freshwater environments. | PloS one 20100101 |
| Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. | PloS one 20100101 |
| Benign cystic mesothelioma of the appendix presenting in a woman: a case report. | Journal of medical case reports 20100101 |
| The potential interaction between clopidogrel and proton pump inhibitors: a systematic review. | BMC medicine 20100101 |
| The pressure exerted on the tracheal wall by two endotracheal tube cuffs: A prospective observational bench-top, clinical and radiological study. | BMC anesthesiology 20100101 |
| Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. | PloS one 20100101 |
| Comparative study of proton pump inhibitors on dexamethasone plus pylorus ligation induced ulcer model in rats. | Indian journal of pharmaceutical sciences 20100101 |
| Complications of regional and general anaesthesia in obstetric practice. | Indian journal of anaesthesia 20100101 |
| Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels. | Mediators of inflammation 20100101 |
| Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase. | Biologics : targets & therapy 20100101 |
| Antiulcer and Anti-inflammatory Activity of Aerial Parts Enicostemma littorale Blume. | Journal of young pharmacists : JYP 20100101 |
| A study on drug-drug interaction of esomeprazole and anti-diabetic drugs. | Journal of young pharmacists : JYP 20100101 |
| High throughput screening for inhibitors of alpha-galactosidase. | Current chemical genomics 20100101 |
| Lafutidine-based triple therapy for Helicobacter pylori eradication. | Hepato-gastroenterology 20100101 |
| Recommendation for optimal management of severe refractory asthma. | Journal of asthma and allergy 20100101 |
| Does pretreatment with proton pump inhibitors influence the eradication rate of Helicobacter pylori? | Hepato-gastroenterology 20100101 |
| Development of theophylline floating microballoons using cellulose acetate butyrate and/or Eudragit RL 100 polymers with different permeability characteristics. | Research in pharmaceutical sciences 20100101 |
| An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease. | Clinical and experimental gastroenterology 20100101 |
| Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and gastroesophageal reflux disease in pediatric patients: a review. | Clinical and experimental gastroenterology 20100101 |
| Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin. | Drug, healthcare and patient safety 20100101 |
| Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases. | Drug, healthcare and patient safety 20100101 |
| Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes. | Frontiers in pharmacology 20100101 |
| Interaction between clopidogrel and proton-pump inhibitors. | Expert review of clinical pharmacology 20100101 |
| Optical sensing with simultaneous electrochemical control in metal nanowire arrays. | Sensors (Basel, Switzerland) 20100101 |
| Emerging antiplatelet agents, differential pharmacology, and clinical utility. | Journal of blood medicine 20100101 |
| The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance? | Clinical pharmacology : advances and applications 20100101 |
| Lack of electrocardiographic effect of dexlansoprazole MR, a novel modified-release formulation of the proton pump inhibitor dexlansoprazole, in healthy participants. | Journal of clinical pharmacology 20091201 |
| [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!]. | Presse medicale (Paris, France : 1983) 20091201 |
| Gastroprotective effect and cytotoxicity of abietane diterpenes from the Chilean Lamiaceae Sphacele chamaedryoides (Balbis) Briq. | The Journal of pharmacy and pharmacology 20091201 |
| Downregulation of immunomodulator gene expression in LPS-stimulated human polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20091201 |
| Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience. | Alimentary pharmacology & therapeutics 20091115 |
| Optimization of melt pelletization in a high shear mixer. | International journal of pharmaceutics 20091103 |
| Comparing the acid-suppressive effects of three brands of generic lansoprazole with the original: pharmacokinetic bioequivalence tests do not necessarily guarantee pharmacodynamic equivalence. | Digestive diseases and sciences 20091101 |
| Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief. | Alimentary pharmacology & therapeutics 20091101 |
| Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20091101 |
| 1-(2-Hydr-oxy-4,5-dimeth-oxyphen-yl)propan-1-one. | Acta crystallographica. Section E, Structure reports online 20091101 |
| Long-term treatment with proton pump inhibitor is associated with undesired weight gain. | World journal of gastroenterology 20091014 |
| [Evaluation of preferences in patients with gastroesophageal reflux disease and dysphagia concerning treatment with lansoprazole orally disintegrating tablets]. | Gastroenterologia y hepatologia 20091001 |
| Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1. | The Journal of pharmacology and experimental therapeutics 20091001 |
| Dexlansoprazole MR. | Expert opinion on pharmacotherapy 20091001 |
| Linear and loglinear structural mean models to evaluate the benefits of an on-demand dosing regimen. | Clinical trials (London, England) 20091001 |
| Cough syncope induced by gastroesophageal reflux disease. | Journal of cardiology 20091001 |
| Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction. | World journal of gastroenterology 20090921 |
| Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials. | Alimentary pharmacology & therapeutics 20090915 |
| Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? | World journal of gastroenterology 20090914 |
| Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects. | Alimentary pharmacology & therapeutics 20090901 |
| Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOL. | Journal of medical economics 20090901 |
| Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole. | Journal of clinical biochemistry and nutrition 20090901 |
| Effects of Lansoprazole on the Lipopolysaccharide-Stimulated Toll-Like Receptor 4 Signal Transduction Systems: A Study Using the 293hTLR4/MD2-CD14 Cells. | Journal of clinical biochemistry and nutrition 20090901 |
| Development and validation of an enantioselective and chemoselective HPLC method using a Chiralpak IA column to simultaneously quantify (R)-(+)- and (S)-(-)-lansoprazole enantiomers and related impurities. | Journal of pharmaceutical and biomedical analysis 20090815 |
| Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease. | European journal of clinical pharmacology 20090801 |
| Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study. | Annals of hematology 20090801 |
| High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090801 |
| The relationship between parenting and delinquency: a meta-analysis. | Journal of abnormal child psychology 20090801 |
| Long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis. | Digestive diseases and sciences 20090801 |
| Prevalence of antimicrobial resistance in Helicobacter pylori isolates in Taiwan in relation to consumption of antimicrobial agents. | International journal of antimicrobial agents 20090801 |
| Association of collagenous colitis with prurigo nodularis. | European journal of gastroenterology & hepatology 20090801 |
| [13C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole. | Alimentary pharmacology & therapeutics 20090801 |
| A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. | Journal of the American Geriatrics Society 20090801 |
| Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study. | Journal of cardiovascular pharmacology 20090801 |
| Potential of lansoprazole as a novel probe for cytochrome P450 3A activity by measuring lansoprazole sulfone in human liver microsomes. | Biological & pharmaceutical bulletin 20090801 |
| Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? | Helicobacter 20090801 |
| Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. | Clinics (Sao Paulo, Brazil) 20090801 |
| Optimisation and validation of a new CE method for the determination of lansoprazole enantiomers in pharmaceuticals. | Electrophoresis 20090801 |
| Rebamipide and mosapride enhance pilocarpine-induced salivation. | North American journal of medical sciences 20090801 |
| Transmucosal gastric leak induced by proton pump inhibitors. | Digestive diseases and sciences 20090701 |
| Microscopic colitis associated with omeprazole and esomeprazole exposure. | Journal of clinical gastroenterology 20090701 |
| CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole. | European journal of clinical pharmacology 20090701 |
| Proton pump inhibitors as a treatment method for type II diabetes. | Medical hypotheses 20090701 |
| Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. | Biomedical chromatography : BMC 20090701 |
| Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease. | European heart journal 20090701 |
| Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole. | Alimentary pharmacology & therapeutics 20090701 |
| Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment. | The American journal of the medical sciences 20090701 |
| Efficacy of a single 24-hour pre-anesthetic dose of proton pump inhibitors. | Journal of gastroenterology and hepatology 20090701 |
| The expression of heme oxygenase-1 induced by lansoprazole. | Journal of clinical biochemistry and nutrition 20090701 |
| Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor-alpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuclear Factor-kappaB and Extracellular Signal-Regulated Kinase. | Journal of clinical biochemistry and nutrition 20090701 |
| Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies. | Postgraduate medicine 20090701 |
| The clinical safety of long-term lansoprazole for the maintenance of healed erosive oesophagitis. | Alimentary pharmacology & therapeutics 20090615 |
| Interaction between clopidogrel and proton pump inhibitors. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090609 |
| Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects. | European journal of clinical pharmacology 20090601 |
| Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers. | Clinical research in cardiology : official journal of the German Cardiac Society 20090601 |
| Lansoprazole, ranitidine, and metoclopramide: comparison of practice patterns at 4 level III NICUs within one healthcare system. | Advances in neonatal care : official journal of the National Association of Neonatal Nurses 20090601 |
| Intubation-induced tracheal stenosis -- the urgent need for permanent solution. | Middle East journal of anaesthesiology 20090601 |
| Differential pulse polarographic investigation of lansoprazole and rabeprazole using dropping mercury electrode. | Die Pharmazie 20090601 |
| Hypersensitivity to proton pump inhibitors: lansoprazole-induced Kounis syndrome. | International journal of cardiology 20090529 |
| Lansoprazole-associated collagenous colitis: diffuse mucosal cloudiness mimicking ulcerative colitis. | World journal of gastroenterology 20090507 |
| Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. | British journal of cancer 20090505 |
| Lansoprazole for long-term maintenance therapy of erosive esophagitis: double-blind comparison with ranitidine. | Digestive diseases and sciences 20090501 |
| Unique endoscopy findings in collagenous colitis. | Gastrointestinal endoscopy 20090501 |
| Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity. | Experimental neurology 20090501 |
| Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy. | Alimentary pharmacology & therapeutics 20090501 |
| The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor. | The American journal of gastroenterology 20090501 |
| Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change. | Journal of managed care pharmacy : JMCP 20090501 |
| Endoscopic submucosal dissection in the era of proton pump inhibitors. | Journal of clinical biochemistry and nutrition 20090501 |
| [Eosinophilic esophagitis: report of three cases]. | Revista medica de Chile 20090501 |
| Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor--evidence for dosing flexibility. | Alimentary pharmacology & therapeutics 20090415 |
| Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD. | Journal of clinical gastroenterology 20090401 |
| Highly sensitive method for the determination of omeprazole in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study. | Biomedical chromatography : BMC 20090401 |
| Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts. | Annals of the rheumatic diseases 20090401 |
| Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. | The Journal of pediatrics 20090401 |
| Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients. | Drug metabolism and disposition: the biological fate of chemicals 20090401 |
| Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation--results from two randomized controlled studies. | Alimentary pharmacology & therapeutics 20090401 |
| Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis. | Alimentary pharmacology & therapeutics 20090401 |
| Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects. | Journal of clinical pharmacology 20090401 |
| Stop the PPI express: they don't keep babies quiet! | The Journal of pediatrics 20090401 |
| Dexlansoprazole (Kapidex) for GERD and erosive esophagitis. | The Medical letter on drugs and therapeutics 20090323 |
| Association of laryngopharyngeal manifestations and gastroesophageal reflux. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20090301 |
| Controlled, household-randomized, open-label trial of the effect of treatment of Helicobacter pylori infection on iron deficiency among children in rural Alaska: results at 40 months. | The Journal of infectious diseases 20090301 |
| Lansoprazole-induced acute interstitial nephritis. | Southern medical journal 20090301 |
| Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials. | Current medical research and opinion 20090301 |
| Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication. | Journal of clinical biochemistry and nutrition 20090301 |
| Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. | World journal of gastroenterology 20090227 |
| Prevalence of ergot derivatives in natural ryegrass pastures: detection and pathogenicity in the horse. | Theriogenology 20090201 |
| Acido-basic properties of proton pump inhibitors in aqueous solutions. | Drug development and industrial pharmacy 20090101 |
| Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH. | European journal of clinical pharmacology 20090101 |
| Effect of oral lansoprazole on intragastric pH after endoscopic treatment for bleeding peptic ulcer. | Scandinavian journal of gastroenterology 20090101 |
| On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor. | Alimentary pharmacology & therapeutics 20090101 |
| Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies. | Clinical drug investigation 20090101 |
| Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy. | British journal of clinical pharmacology 20090101 |
| Effect of oral lansoprazole on intragastric pH after endoscopic treatment for bleeding peptic ulcer. | Scandinavian journal of gastroenterology 20090101 |
| Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. | PloS one 20090101 |
| Magnet induced perforated appendicitis and ileo-caecal fistula formation. | The Ulster medical journal 20090101 |
| Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. | BMC clinical pharmacology 20090101 |
| Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors. | Journal of investigational allergology & clinical immunology 20090101 |
| Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disorders. | Drugs 20090101 |
| Treatment and chemoprevention of NSAID-associated gastrointestinal complications. | Therapeutics and clinical risk management 20090101 |
| Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. | Paediatric drugs 20090101 |
| Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication. | BMC gastroenterology 20090101 |
| Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion. | PloS one 20090101 |
| Lansoprazole is an uncompetitive inhibitor of tissue-nonspecific alkaline phosphatase. | Acta biochimica Polonica 20090101 |
| Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH. | Hepato-gastroenterology 20090101 |
| Influences of CYP2C19 polymorphism on recurrence of reflux esophagitis during proton pump inhibitor maintenance therapy. | Hepato-gastroenterology 20090101 |
| Eradication of Helicobacter pylori in follicular and nonfollicular gastritis. | Hepato-gastroenterology 20090101 |
| Proton pump inhibitors--their pharmacological impact on the clinical management of acid-related disorders. | Arzneimittel-Forschung 20090101 |
| Congenital heart block associated with Sjögren syndrome: case report. | International archives of medicine 20090101 |
| Pulmonary manifestations of gastroesophageal reflux disease. | Annals of thoracic medicine 20090101 |
| Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. | BMJ (Clinical research ed.) 20090101 |
| Cronkhite-Canada Syndrome: Gastric Involvement Diagnosed by MDCT. | Case reports in medicine 20090101 |
| Five-Year Long-Term Followup of a Primary Lymph node Gastrinoma: Is a Pancreaticoduodenectomy Justified? | Case reports in medicine 20090101 |
| Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis? | Clinical and experimental rheumatology 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| Acute kidney injury in patients with inactive cytochrome P450 polymorphisms. | Renal failure 20090101 |
| An unusually long appendix in a child: a case report. | Cases journal 20090101 |
| Collagenous gastritis, a new spectrum of disease in pediatric patients: two case reports. | Cases journal 20090101 |
| Lansoprazole-associated collagenous colitis: unique presentation, similar to ischemic colitis. | Endoscopy 20090101 |
| Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study. | Clinical drug investigation 20090101 |
| Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention. | Vascular health and risk management 20090101 |
| Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles. | Arthritis research & therapy 20090101 |
| Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis. | BMC urology 20090101 |
| Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication. | Arquivos de gastroenterologia 20090101 |
| Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study. | BMC gastroenterology 20090101 |
| Pantoprazole: a proton pump inhibitor. | Clinical drug investigation 20090101 |
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome concomitant with systemic sclerosis, immune thrombocytopenic purpura. | Internal medicine (Tokyo, Japan) 20090101 |
| Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles. | PloS one 20090101 |
| [Lanzoptol efficiency for heartburn alleviation in patients with NERD]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101 |
| Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting. | Vascular health and risk management 20090101 |
| Lanthanum associated abnormal liver function tests in two patients on dialysis: a case report. | Journal of medical case reports 20090101 |
| Urticaria and infections. | Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20090101 |
| Gastroesophageal reflux disease: medical or surgical treatment? | Gastroenterology research and practice 20090101 |
| [Morphological changes in the intestinal mucosa of the large intestine under the blockage of H+,K+ -ATPase and CCK-2 gastrin receptors]. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20090101 |
| New sensitive kinetic spectrophotometric methods for determination of omeprazole in dosage forms. | International journal of analytical chemistry 20090101 |
| Long-Term Alendronate Use Not without Consequences? | International journal of rheumatology 20090101 |
| High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. | Neural plasticity 20090101 |
| The Case of the Infection that Wasn't ! | Journal of global infectious diseases 20090101 |
| Asthma and gastroesophageal reflux: End of the blame game. | Lung India : official organ of Indian Chest Society 20090101 |
| Prolonged gastric stasis of enteric-coated granules. | BMJ case reports 20090101 |
| Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis. | Clinical and experimental gastroenterology 20090101 |
| Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. | Drug, healthcare and patient safety 20090101 |
| [A study on the subjective compliance and acceptance of oral lanzoprazole in traumatology. The ECOFT-TR Study]. | Reumatologia clinica 20090101 |
| Severe hypomagnesaemia due to lansoprazole. | BMJ case reports 20090101 |
| Determination of lansoprazole in human plasma by rapid resolution liquid chromatography-electrospray tandem mass spectrometry: application to a bioequivalence study on Chinese volunteers. | Journal of pharmaceutical and biomedical analysis 20081215 |
| [Nocturnal shortness of breath: in asthma look for reflux -- is it worthwhile?]. | MMW Fortschritte der Medizin 20081211 |
| Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial. | Alimentary pharmacology & therapeutics 20081201 |
| Simultaneous determination of lansoprazole and its metabolites 5'-hydroxy lansoprazole and lansoprazole sulphone in human plasma by LC-MS/MS: application to a pharmacokinetic study in healthy volunteers. | Journal of pharmaceutical and biomedical analysis 20081201 |
| Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis. | Helicobacter 20081201 |
| Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea. | Helicobacter 20081201 |
| Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial. | Helicobacter 20081201 |
| Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study. | Helicobacter 20081201 |
| The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor. | International journal of clinical practice 20081201 |
| Co-circulation of two sublineages of HPAI H5N1 virus in the Kingdom of Saudi Arabia with unique molecular signatures suggesting separate introductions into the commercial poultry and falconry sectors. | The Journal of general virology 20081101 |
| [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]. | Presse medicale (Paris, France : 1983) 20081001 |
| Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment. | Gastrointestinal endoscopy 20081001 |
| Proton pump inhibitors: an update of their clinical use and pharmacokinetics. | European journal of clinical pharmacology 20081001 |
| Dexlansoprazole, a modified release formulation of an enantiomer of lansoprazole, for the treatment of reflux esophagitis. | Current opinion in investigational drugs (London, England : 2000) 20081001 |
| Lansoprazole in globus pharyngeus: double-blind, randomized, placebo-controlled trial. | Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 20081001 |
| Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community. | Helicobacter 20081001 |
| Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. | Gut 20080901 |
| Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. | Lancet (London, England) 20080802 |
| Phylogenetic diversity and spatial distribution of the microbial community associated with the Caribbean deep-water sponge Polymastia cf. corticata by 16S rRNA, aprA, and amoA gene analysis. | Microbial ecology 20080801 |
| Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. | Diabetes care 20080801 |
| Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. | American journal of physiology. Heart and circulatory physiology 20080801 |
| Proton pump inhibitors may increase the risk of delayed bleeding complications after open heart surgery if used concomitantly with warfarin. | The Thoracic and cardiovascular surgeon 20080801 |
| Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina? | Journal of cardiology 20080801 |
| TSCOT+ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentation. | PLoS biology 20080801 |
| [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801 |
| Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients. | Alimentary pharmacology & therapeutics 20080801 |
| Relationship between herd size and the prevalence of PRRS in pig herds in China. | The Veterinary record 20080719 |
| Watermelon stomach. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080715 |
| Endoscopic patterns and histopathological features after eradication therapy in Helicobacter pylori-associated nodular gastritis. | Digestive diseases and sciences 20080701 |
| The effect of subchronic administration of 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526), a novel acid pump antagonist, on gastric acid secretion and gastrin levels in rats. | The Journal of pharmacology and experimental therapeutics 20080701 |
| Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. | Diseases of the colon and rectum 20080701 |
| Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. | Alimentary pharmacology & therapeutics 20080701 |
| Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. | Biochemical pharmacology 20080701 |
| Anticholinergic activity of 107 medications commonly used by older adults. | Journal of the American Geriatrics Society 20080701 |
| Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080701 |
| Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat. | Pharmacological research 20080701 |
| Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. | World journal of gastroenterology 20080628 |
| Genotyping of Cryptosporidium isolates from human clinical cases in Poland. | Parasitology research 20080601 |
| Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors. | Alimentary pharmacology & therapeutics 20080601 |
| Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers. | Gastroenterology 20080601 |
| Preformulation considerations for controlled release dosage forms. Part II. Selected candidate support. | AAPS PharmSciTech 20080601 |
| Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis. | Gastrointestinal endoscopy 20080601 |
| Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. | The AAPS journal 20080601 |
| High-pressure water injection injury. | International journal of emergency medicine 20080601 |
| Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal. | The Journal of biological chemistry 20080523 |
| Multimilligram enantioresolution of sulfoxide proton pump inhibitors by liquid chromatography on polysaccharide-based chiral stationary phase. | Journal of pharmaceutical and biomedical analysis 20080512 |
| Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers. | European journal of clinical pharmacology 20080501 |
| Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians. | British journal of clinical pharmacology 20080501 |
| Semipreparative chiral supercritical fluid chromatography in the fractionation of lansoprazole and two related antiulcer drugs enantiomers. | Journal of separation science 20080501 |
| Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. | Scandinavian journal of gastroenterology 20080501 |
| A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). | Endoscopy 20080501 |
| Reflux masquerader: acute Helicobacter pylori infection in neonates and infants. | Journal of pediatric gastroenterology and nutrition 20080501 |
| Comparison of investigation modalities for evaluation of esophageal peristaltic function. | Journal of clinical biochemistry and nutrition 20080501 |
| Gastric epithelial cell modality and proton pump inhibitor. | Journal of clinical biochemistry and nutrition 20080501 |
| Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors? | World journal of gastroenterology 20080428 |
| The alternating current polarographic behavior and determination of lansoprazole and omeprazole in dosage forms and biological fluids. | Journal of biochemical and biophysical methods 20080424 |
| Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole. | World journal of gastroenterology 20080421 |
| Extraintestinal heterotopic gastric tissue simulating acute appendicitis. | World journal of gastroenterology 20080414 |
| Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers. | World journal of gastroenterology 20080407 |
| Prospective object search in dogs: mixed evidence for knowledge of What and Where. | Animal cognition 20080401 |
| Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept. | American journal of hematology 20080401 |
| Is lansoprazole effective for the initial management of young patients with dyspepsia? | Nature clinical practice. Gastroenterology & hepatology 20080401 |
| Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. | Journal of clinical pharmacology 20080401 |
| [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080401 |
| Persistent atrial fibrillation associated with gastroesophageal reflux accompanied by hiatal hernia. | Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20080401 |
| Pantoprazole: from drug metabolism to clinical relevance. | Expert opinion on drug metabolism & toxicology 20080401 |
| Acute interstitial nephritis related to lansoprazole administration. | JPMA. The Journal of the Pakistan Medical Association 20080401 |
| Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20080401 |
| Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults. | Alimentary pharmacology & therapeutics 20080315 |
| Effect of Helicobacter pylori eradication on gastric carcinogenesis. | Laboratory investigation; a journal of technical methods and pathology 20080301 |
| The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. | Journal of clinical gastroenterology 20080301 |
| Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusion. | Pharmacotherapy 20080301 |
| Evidence for the ''paradox'' association between hypertensive lower esophageal sphincter and gastroesophageal reflux disease. | Minerva gastroenterologica e dietologica 20080301 |
| Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux. | Journal of pediatric gastroenterology and nutrition 20080301 |
| Proton pump inhibitors and gastritis. | Journal of clinical biochemistry and nutrition 20080301 |
| Long-term Ultrasonographic Follow-up Study of Gastric Motility in Patients with Functional Dyspepsia. | Journal of clinical biochemistry and nutrition 20080301 |
| Cyclopamine inhibition of the sonic hedgehog pathway in the stomach requires concomitant acid inhibition. | Regulatory peptides 20080207 |
| Long-term proton pump inhibitor use in children: a retrospective review of safety. | Digestive diseases and sciences 20080201 |
| Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor. | Journal of gastroenterology and hepatology 20080201 |
| Pharmacological compliance and acceptability of lansoprazole orally disintegrating tablets in primary care. | Current medical research and opinion 20080201 |
| Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection. | Journal of clinical gastroenterology 20080201 |
| Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation. | Therapeutic drug monitoring 20080201 |
| Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. | European journal of clinical pharmacology 20080201 |
| Gastroprotective activity of ferruginol in mice and rats: effects on gastric secretion, endogenous prostaglandins and non-protein sulfhydryls. | The Journal of pharmacy and pharmacology 20080201 |
| [Pharmacological and clinical profile of lansoprazole (Takepron IV injection 30 mg)]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080201 |
| Management of laryngopharyngeal reflux with proton pump inhibitors. | Therapeutics and clinical risk management 20080201 |
| Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy. | Journal of gastroenterology and hepatology 20080101 |
| Effects of dexmedetomidine infusion in patients undergoing functional endoscopic sinus surgery under local anaesthesia. | European journal of anaesthesiology 20080101 |
| Genotype 3 hepatitis E has been widespread in pig farms of Shanghai suburbs. | Veterinary microbiology 20080101 |
| Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects. | Alimentary pharmacology & therapeutics 20080101 |
| Proton pump inhibitors: do differences in pharmacokinetics translate into differences in clinical outcomes? | Clinical pharmacokinetics 20080101 |
| Superior mesenteric artery syndrome: an uncommon cause of feeding intolerance in infancy. | Journal of pediatric gastroenterology and nutrition 20080101 |
| Lansoprazole was not effective in young dyspeptic patients without Helicobacter pylori. | ACP journal club 20080101 |
| Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. | Acta dermato-venereologica 20080101 |
| A novel 'peak parking' strategy for ultra-performance liquid chromatography/tandem mass spectrometric detection for enhanced performance of bioanalytical assays. | Rapid communications in mass spectrometry : RCM 20080101 |
| Transparent meta-analysis of prospective memory and aging. | PloS one 20080101 |
| Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20080101 |
| High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. | World journal of surgical oncology 20080101 |
| Reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation. | Korean journal of radiology 20080101 |
| Stereoselective disposition of proton pump inhibitors. | Clinical drug investigation 20080101 |
| A middle-aged female with recurrent sinopulmonary infections: a case report. | Journal of medical case reports 20080101 |
| Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5. | Drug metabolism and pharmacokinetics 20080101 |
| Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors. | BMC gastroenterology 20080101 |
| Persistent oxidative stress in the corpus mucosa is evoked by long-term treatment of H. pylori-infected patients with proton pump inhibitors. | Hepato-gastroenterology 20080101 |
| Absence of gastrointestinal infections in a cohort of patients with Zollinger-Ellison syndrome and other acid hypersecretors receiving long-term acid suppression with lansoprazole. | BMC gastroenterology 20080101 |
| Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy. | BMC gastroenterology 20080101 |
| Activation and stabilization of drugs by supramolecular pKa shifts: drug-delivery applications tailored for cucurbiturils. | Angewandte Chemie (International ed. in English) 20080101 |
| Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials. | Drug safety 20080101 |
| Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year. | Paediatric drugs 20080101 |
| Age-dependent pharmacokinetics of lansoprazole in neonates and infants. | Paediatric drugs 20080101 |
| Hypokalemic rhabdomyolysis in a patient with a laparoscopic adjustable gastric banding. | La Clinica terapeutica 20080101 |
| Helicobacter pylori and gastroesophageal reflux disease. | World journal of surgical oncology 20080101 |
| Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies. | Reviews in gastroenterological disorders 20080101 |
| Gastroprotective and anti-oxidative properties of ascorbic acid on indomethacin-induced gastric injuries in rats. | Biological trace element research 20080101 |
| Triple therapies plus different probiotics for Helicobacter pylori eradication. | European review for medical and pharmacological sciences 20080101 |
| Simultaneous fundoplication and gastric stimulation in a lung transplant recipient with gastroparesis and reflux. | JSLS : Journal of the Society of Laparoendoscopic Surgeons 20080101 |
| Role of cytochrome P450 in drug interactions. | Nutrition & metabolism 20080101 |
| A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. | Digestion 20080101 |
| Henoch-Schönlein purpura associated with Helicobacter pylori infection in a child. | Pediatric dermatology 20080101 |
| Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial. | BMJ (Clinical research ed.) 20080101 |
| Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study. | Arthritis research & therapy 20080101 |
| The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study. | Journal of gastroenterology 20080101 |
| [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| Appendicitis epiploicae: An unusual cause of acute abdomen in children. | Journal of Indian Association of Pediatric Surgeons 20080101 |
| Laparoscopic appendicectomy is a favorable alternative for complicated appendicitis in children. | Journal of Indian Association of Pediatric Surgeons 20080101 |
| Solitary mesenteric vascular anomaly presenting as acute abdomen. | Journal of Indian Association of Pediatric Surgeons 20080101 |
| Spectrophotometric determination of certain benzimidazole proton pump inhibitors. | Indian journal of pharmaceutical sciences 20080101 |
| Simultaneous spectrophotometric determination of lansoprazole and domperidone in capsule dosage form. | Indian journal of pharmaceutical sciences 20080101 |
| Simultaneous Estimation of Esomeprazole and Domperidone by UV Spectrophotometric Method. | Indian journal of pharmaceutical sciences 20080101 |
| An unusual cause of 'pleuritic' chest pain. | Acute medicine 20080101 |
| [Therapeutic innovations in gastroesophageal reflux]. | Presse medicale (Paris, France : 1983) 20071201 |
| Stability of partial doses of omeprazole-sodium bicarbonate oral suspension. | The Annals of pharmacotherapy 20071201 |
| Rivastigmine-induced dystonia. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071201 |
| Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071201 |
| Population pharmacokinetics and proton pump inhibitory effects of intravenous lansoprazole in healthy Japanese males. | Biological & pharmaceutical bulletin 20071201 |
| Peripheral arterial disease in the elderly. | Clinical interventions in aging 20071201 |
| Dyspepsia in childhood and adolescence: insights and treatment considerations. | Current gastroenterology reports 20071201 |
| Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. | Therapeutics and clinical risk management 20071201 |
| Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy. | Clinical endocrinology 20071101 |
| Pseudochromhidrosis: blue discolouration of the head and neck. | The Australasian journal of dermatology 20071101 |
| The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. | Journal of digestive diseases 20071101 |
| Gastroprotective and antioxidant effects of amiodarone on indomethacin-induced gastric ulcers in rats. | Archives of pharmacal research 20071101 |
| [Drug treatment and surgical indications in gastroesophageal reflux]. | Revista de gastroenterologia de Mexico 20071101 |
| Exhaled breath marker in asthma patients with gastroesophageal reflux disease. | Journal of clinical biochemistry and nutrition 20071101 |
| Lansoprazole Novel Effector Sites Revealed by Autoradiography: Relation to Helicobacter pylori, Colon, Esophagus and Others. | Journal of clinical biochemistry and nutrition 20071101 |
| A novel phenol-bound pectic polysaccharide from Decalepis hamiltonii with multi-step ulcer preventive activity. | World journal of gastroenterology 20071021 |
| Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. | Digestive diseases and sciences 20071001 |
| Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526). | The Journal of pharmacology and experimental therapeutics 20071001 |
| Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071001 |
| Gastroprotective effect of mangiferin, a xanthonoid from Mangifera indica, against gastric injury induced by ethanol and indomethacin in rodents. | Planta medica 20071001 |
| Proton pump inhibitor utilization patterns in infants. | Journal of pediatric gastroenterology and nutrition 20071001 |
| Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia. | Alimentary pharmacology & therapeutics 20070915 |
| Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. | World journal of gastroenterology 20070907 |
| Inhibition of gastric H(+),K(+)-ATPase and Helicobacter pylori growth by phenolic antioxidants of Curcuma amada. | Journal of agricultural and food chemistry 20070905 |
| Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20070901 |
| Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles. | Chirality 20070901 |
| Study on reaction kinetics of synthesis of thioether by a visualization technique. | Journal of colloid and interface science 20070901 |
| [Collagenous colitis. Clinicopathological study of 18 cases]. | Revista clinica espanola 20070901 |
| Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori. | Alimentary pharmacology & therapeutics 20070901 |
| Epstein-Barr virus gastritis: an underrecognized form of severe gastritis simulating gastric lymphoma. | The American journal of surgical pathology 20070901 |
| Autoimmune response as a mechanism for a Dobzhansky-Muller-type incompatibility syndrome in plants. | PLoS biology 20070901 |
| Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats. | Journal of pharmacological sciences 20070901 |
| CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor. | Pharmacogenomics 20070901 |
| Anti-inflammatory and anti-oxidative properties of proton pump inhibitors. | Journal of clinical biochemistry and nutrition 20070901 |
| Immune and Inflammatory Responses in GERD and Lansoprazole. | Journal of clinical biochemistry and nutrition 20070901 |
| Lansoprazole-induced improvement of esophageal submucosal injury. | Journal of clinical biochemistry and nutrition 20070901 |
| [Drug-induced microscopic colitis]. | Praxis 20070829 |
| Zollinger Ellison syndrome, treated with lansoprazole, during pregnancy. | Archives of gynecology and obstetrics 20070801 |
| Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy. | European journal of clinical pharmacology 20070801 |
| Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease. | International journal of clinical practice 20070801 |
| Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. | Helicobacter 20070801 |
| Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy. | Helicobacter 20070801 |
| Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy. | Helicobacter 20070801 |
| Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial. | Journal of gastroenterology 20070801 |
| Effect of famotidine and lansoprazole on serum phosphorus levels in hemodialysis patients on calcium carbonate therapy. | Clinical nephrology 20070801 |
| Recent advances in chirally pure proton pump inhibitors. | Journal of the Indian Medical Association 20070801 |
| Role of posaconazole in the management of oropharyngeal and esophageal candidiasis. | Therapeutics and clinical risk management 20070801 |
| A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD). | Therapeutics and clinical risk management 20070801 |
| New onset thyrotoxicosis presenting as vomiting, abdominal pain and transaminitis in the emergency department. | The western journal of emergency medicine 20070801 |
| Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection. | World journal of gastroenterology 20070728 |
| Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. | Digestive diseases and sciences 20070701 |
| Gabapentin-induced severe myopathy. | The Annals of pharmacotherapy 20070701 |
| Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: a randomized controlled trial with 12-month follow-up. | The American journal of gastroenterology 20070701 |
| Effects of uptake and efflux transporter inhibition on erythromycin breath test results. | Clinical pharmacology and therapeutics 20070601 |
| Use of ceric ammonium sulphate and two dyes, methyl orange and indigo carmine, in the determination of lansoprazole in pharmaceuticals. | Acta pharmaceutica (Zagreb, Croatia) 20070601 |
| [Protonic pump inhibitors in kidney transplant patients: efficacy and safety]. | Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20070601 |
| Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. | Hepato-gastroenterology 20070601 |
| Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment? | Journal of gastroenterology 20070601 |
| Long-term management of gastroesophageal reflux disease with pantoprazole. | Therapeutics and clinical risk management 20070601 |
| A review of rabeprazole in the treatment of acid-related diseases. | Therapeutics and clinical risk management 20070601 |
| Gastroprotective effect and cytotoxicity of terpenes from the Paraguayan crude drug 'yagua rova' (Jatropha isabelli). | Journal of ethnopharmacology 20070522 |
| Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients. | Biopharmaceutics & drug disposition 20070501 |
| A shot in the dark: failing to recognize the link between physical and mental illness. | Journal of general internal medicine 20070501 |
| [Cost-effectiveness analysis for the treatment of non-erosive reflux disease]. | Nihon rinsho. Japanese journal of clinical medicine 20070501 |
| [Three cases of muscle tension dysphonia improved using proton pump inhibitors]. | Nihon Jibiinkoka Gakkai kaiho 20070501 |
| [Helicobacter pylori infection and probiotics]. | Nihon saikingaku zasshi. Japanese journal of bacteriology 20070501 |
| Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004. | Journal of toxicology and environmental health. Part A 20070415 |
| Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori. | Clinical pharmacology and therapeutics 20070401 |
| Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070401 |
| Proton pump inhibitors: effective first-line treatment for management of dyspepsia. | Digestive diseases and sciences 20070401 |
| [A case of gastroesophageal reflux disease with marked eosinophilia]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20070401 |
| Gastroprotective effect and cytotoxicity of labdenamides. | Planta medica 20070401 |
| Microscopic colitis associated with lansoprazole: report of two cases and a review of the literature. | Scandinavian journal of gastroenterology 20070401 |
| Lack of effect of gastric acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir in HIV-infected patients. | AIDS patient care and STDs 20070401 |
| [Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice]. | Orvosi hetilap 20070325 |
| Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center. | Alimentary pharmacology & therapeutics 20070315 |
| Influence of H pylori on plasma ghrelin in patients without atrophic gastritis. | World journal of gastroenterology 20070314 |
| Inhibition of gastric H+, K+-ATPase and Helicobacter pylori growth by phenolic antioxidants of Zingiber officinale. | Molecular nutrition & food research 20070301 |
| Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. | The Journal of pediatrics 20070301 |
| Pharmacotherapy for microscopic colitis. | Pharmacotherapy 20070301 |
| Constituents and antiulcer effect of Alchornea glandulosa: activation of cell proliferation in gastric mucosa during the healing process. | Biological & pharmaceutical bulletin 20070301 |
| Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20070301 |
| Key points in the management of gastroesophageal reflux disease. | Current gastroenterology reports 20070301 |
| Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan. | Hepato-gastroenterology 20070301 |
| Long-term management of GERD in the elderly with pantoprazole. | Clinical interventions in aging 20070301 |
| Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. | Analytical and bioanalytical chemistry 20070201 |
| Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy. | Alimentary pharmacology & therapeutics 20070201 |
| Gastroprotective and cytotoxic effect of semisynthetic ferruginol derivatives. | The Journal of pharmacy and pharmacology 20070201 |
| Cytochrome P450 2C19 polymorphism influences the preventive effect of lansoprazole on the recurrence of erosive reflux esophagitis. | Journal of gastroenterology and hepatology 20070201 |
| Update on Helicobacter pylori treatment. | American family physician 20070201 |
| Acid control with esomeprazole and lansoprazole: a comparative dose-response study. | Scandinavian journal of gastroenterology 20070201 |
| Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura. | Platelets 20070201 |
| [Proton pump inhibitors in developmental period medicine]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20070201 |
| Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. | Alimentary pharmacology & therapeutics 20070115 |
| Influence of smoking and CYP2C19 genotypes on H. pylori eradication success. | Epidemiology and infection 20070101 |
| Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070101 |
| Some fibrocystic breast change may be caused by sexually transmitted H. pylori during oral nipple contact: supporting literature and case report of resolution after gut H. pylori eradication treatment. | Medical hypotheses 20070101 |
| Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. | International journal of antimicrobial agents 20070101 |
| Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. | Naunyn-Schmiedeberg's archives of pharmacology 20070101 |
| Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease. | Journal of pediatric gastroenterology and nutrition 20070101 |
| Helicobacter pylori: present status and future prospects in Japan. | Journal of gastroenterology 20070101 |
| Lansoprazole increases serum IgG and IgM in H. pylori-infected patients. | International journal of immunopathology and pharmacology 20070101 |
| Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lansoprazole enantiomers in CYP2C19 extensive metaboliser renal transplant recipients. | Clinical drug investigation 20070101 |
| Eradication of Helicobacter pylori in hemodialysis patients. | Renal failure 20070101 |
| Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. | World journal of surgical oncology 20070101 |
| Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease. | Respiration; international review of thoracic diseases 20070101 |
| [Otorhinolaringologyc approach of the chronic cough. Clinical case]. | Anales otorrinolaringologicos ibero-americanos 20070101 |
| A better cure rate with 800 mg than with 400 mg clarithromycin regimens in one-week triple therapy for Helicobacter pylori infection in cigarette-smoking peptic ulcer patients. | Digestion 20070101 |
| Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. | Arthritis research & therapy 20070101 |
| [The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors]. | Klinicheskaia meditsina 20070101 |
| Local anaesthesia for appendicectomy: one surgeon's experience. | Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20070101 |
| Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis. | Modern rheumatology 20070101 |
| An economic model of long-term use of celecoxib in patients with osteoarthritis. | BMC gastroenterology 20070101 |
| Healing of severe reflux esophagitis with PPI does not improve esophageal dysmotility. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20070101 |
| Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals. | BMC clinical pharmacology 20070101 |
| High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. | Wiener klinische Wochenschrift 20070101 |
| Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101 |
| Role of oxidative stress in lansoprazole-mediated gastric and hepatic protection in Wistar rats. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101 |
| Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer. | Nuclear receptor signaling 20070101 |
| In vivo bactericidal activities of Japanese rice-fluid against H. pylori in a Mongolian gerbil model. | International journal of medical sciences 20070101 |
| Proton pump inhibitor-responsive chronic cough without acid reflux: a case report. | Journal of medical case reports 20070101 |
| Xiphodynia: a diagnostic conundrum. | Chiropractic & osteopathy 20070101 |
| Acceptability of lansoprazole orally disintegrating tablets in patients with gastro-oesophageal reflux disease : ACEPTO study. | Clinical drug investigation 20070101 |
| Acute presentation of a solitary caecal diverticulum: a case report. | Journal of medical case reports 20070101 |
| Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice. | Microbiology and immunology 20070101 |
| External validation of a measurement tool to assess systematic reviews (AMSTAR). | PloS one 20070101 |
| A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori. | Digestion 20070101 |
| Inflammation and oxidative stress in gastroesophageal reflux disease. | Journal of clinical biochemistry and nutrition 20070101 |
| [Influence of omeprasole and lansoprasole on Na+, K+ -ATPase and Mg2+ -ATPase activity of the plasmatic membrane of myometrium smooth muscle cells]. | Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20070101 |
| Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20061201 |
| Specific H+/K(+)-ATPase inhibitors decreased contractile responses of isolated rat vas deferens. | Pharmacological research 20061201 |
| Serosal appendicitis: incidence, causes and clinical significance. | Postgraduate medical journal 20061201 |
| Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan. | Japanese journal of infectious diseases 20061201 |
| Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus. | International journal of clinical pharmacology and therapeutics 20061201 |
| An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube. | Alimentary pharmacology & therapeutics 20061201 |
| Pyroderma gangrenosum: resolution after treatment for Helicobacter pylori. | Journal of the South Carolina Medical Association (1975) 20061201 |
| Common antacids could help keep gingivitis at bay. | British dental journal 20061125 |
| [Safety of proton pump inhibitors]. | Medicina clinica 20061125 |
| A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study. | Alimentary pharmacology & therapeutics 20061115 |
| An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. | Alimentary pharmacology & therapeutics 20061115 |
| Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia. | Archives of oral biology 20061101 |
| Suppression of proinflammatory cytokine production in macrophages by lansoprazole. | Pediatric surgery international 20061101 |
| Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use? | International journal of clinical practice 20061101 |
| Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20061101 |
| Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20061101 |
| Gastroprotective activity and cytotoxic effect of cyperenoic acid derivatives. | The Journal of pharmacy and pharmacology 20061101 |
| Treatment of gastroesophageal reflux disease. | Jornal de pediatria 20061101 |
| Safety profile of proton pump inhibitors according to the spontaneous reports of suspected adverse reactions. | International journal of clinical pharmacology and therapeutics 20061101 |
| Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. | Clinical therapeutics 20061101 |
| [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens]. | Zhonghua yi xue za zhi 20061017 |
| An in vitro investigation on acid catalyzed reactions of proton pump inhibitors in the absence of an electrophile. | International journal of pharmaceutics 20061012 |
| Endoplasmic reticulum stress response is involved in the pathogenesis of stress induced gastric lesions in rats. | Life sciences 20061004 |
| Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. | Helicobacter 20061001 |
| Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial. | Journal of clinical pharmacology 20061001 |
| The role of proton-pump inhibitor therapy in patients with gastroesophageal reflux disease and difficult-to-control asthma. | Expert opinion on pharmacotherapy 20061001 |
| [Dosaging of proton pumps inhibitors]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060921 |
| Gastroesophageal reflux disease in 2006. The imperfect diagnosis. | Pediatric radiology 20060901 |
| Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism. | Journal of gastroenterology and hepatology 20060901 |
| Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. | Alimentary pharmacology & therapeutics 20060901 |
| The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study. | Methods and findings in experimental and clinical pharmacology 20060901 |
| Gastroprotective and ulcer-healing activity of oleanolic acid derivatives: in vitro-in vivo relationships. | Life sciences 20060829 |
| Contrast-enhanced ultrasonographic assessment of the response of Ménétrier disease to Helicobacter pylori eradication therapy. | Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 20060801 |
| Pharmacoeconomic comparison of Helicobacter pylori eradication regimens. | Pharmacy world & science : PWS 20060801 |
| The role of molecular interaction fields on enantioselective and nonselective separation of chiral sulfoxides. | Journal of chromatography. A 20060714 |
| Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. | Biochemical and biophysical research communications 20060707 |
| Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060701 |
| A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. | The Tohoku journal of experimental medicine 20060701 |
| Who ate whom? Adaptive Helicobacter genomic changes that accompanied a host jump from early humans to large felines. | PLoS genetics 20060701 |
| Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy. | Clinical pharmacology and therapeutics 20060701 |
| The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. | The American journal of gastroenterology 20060701 |
| Enantiomeric separation of chiral sulfoxides by supercritical fluid chromatography. | Journal of separation science 20060701 |
| Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study. | Journal of gastroenterology 20060701 |
| Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. | International journal of clinical pharmacology and therapeutics 20060701 |
| Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy. | World journal of gastroenterology 20060628 |
| Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection. | Helicobacter 20060601 |
| Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area. | Helicobacter 20060601 |
| Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH. | Alimentary pharmacology & therapeutics 20060601 |
| Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products. | Chemical & pharmaceutical bulletin 20060601 |
| Enantioselective disposition of lansoprazole and rabeprazole in human plasma. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060601 |
| Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? | European journal of clinical pharmacology 20060601 |
| Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve. | Therapeutic drug monitoring 20060601 |
| Age-related changes in event-cued visual and auditory prospective memory proper. | Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition 20060601 |
| Pill esophagitis caused by telithromycin: a case report. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20060601 |
| [Effects of proton pump inhibitor on airway hyperresponsiveness in asthmatics with gastroesophageal reflux]. | Arerugi = [Allergy] 20060601 |
| Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20060515 |
| Degradation of lansoprazole and omeprazole in the aquatic environment. | Chemosphere 20060501 |
| Ion flow regulates left-right asymmetry in sea urchin development. | Development genes and evolution 20060501 |
| Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy. | Alimentary pharmacology & therapeutics 20060501 |
| Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. | Digestive diseases and sciences 20060501 |
| Hydroxyl radical scavenging reactivity of proton pump inhibitors. | Biochemical pharmacology 20060428 |
| Gastroprotective and ulcer healing effect of ferruginol in mice and rats: assessment of its mechanism of action using in vitro models. | Life sciences 20060418 |
| Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole. | Alimentary pharmacology & therapeutics 20060415 |
| In silico and in vitro screening for inhibition of cytochrome P450 CYP3A4 by comedications commonly used by patients with cancer. | Drug metabolism and disposition: the biological fate of chemicals 20060401 |
| Comparison of the effects of proton pump inhibitors on human plasma adrenocorticotropic hormone and cortisol levels under the starved condition. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20060401 |
| Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h. | Alimentary pharmacology & therapeutics 20060401 |
| Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages. | Alimentary pharmacology & therapeutics 20060401 |
| A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. | Clinical pharmacology and therapeutics 20060401 |
| Design and evaluation of jingzhiguanxin monolithic osmotic pump tablet. | Chemical & pharmaceutical bulletin 20060401 |
| Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. | World journal of gastroenterology 20060321 |
| Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. | Alimentary pharmacology & therapeutics 20060315 |
| Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease. | Respiratory medicine 20060301 |
| Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event. | Rheumatology (Oxford, England) 20060301 |
| Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes. | British journal of clinical pharmacology 20060301 |
| Hydroxylation of lansoprazole in poor metabolizers of CYP2C19. | British journal of clinical pharmacology 20060301 |
| Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers. | Pharmacotherapy 20060301 |
| Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors. | The Journal of allergy and clinical immunology 20060301 |
| Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20060301 |
| Microscopic colitis associated with exposure to lansoprazole. | The Medical journal of Australia 20060220 |
| [Gastric protection and treatment with low-dose aspirin]. | Medicina clinica 20060218 |
| Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries. | European journal of pharmacology 20060215 |
| Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060201 |
| Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype. | European journal of clinical pharmacology 20060201 |
| Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20060201 |
| Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. | World journal of gastroenterology 20060107 |
| Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20060101 |
| Fatal toxic epidermal necrolysis due to lansoprazole. | Clinical and experimental dermatology 20060101 |
| Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. | International journal of molecular medicine 20060101 |
| Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19. | Clinical pharmacology and therapeutics 20060101 |
| Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study. | Digestive diseases and sciences 20060101 |
| Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060101 |
| Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060101 |
| Cholecystoduodenal fistula secondary to penetrating duodenal ulcer: a case of conservative management. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20060101 |
| Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole. | Xenobiotica; the fate of foreign compounds in biological systems 20060101 |
| [Pseudomembranous colitis after Helicobacter pylori eradication therapy]. | Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20060101 |
| Intravenous proton pump inhibitors. | Reviews in gastroenterological disorders 20060101 |
| Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study. | BMC health services research 20060101 |
| Fatality after deliberate ingestion of sustained-release ibuprofen: a case report. | Critical care (London, England) 20060101 |
| Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites. | Clinical hemorheology and microcirculation 20060101 |
| Functional complementation of the yeast P-type H-ATPase, PMA1, by the Pneumocystis carinii P-type H-ATPase, PCA1. | The Journal of eukaryotic microbiology 20060101 |
| A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide. | Journal of gastroenterology and hepatology 20060101 |
| Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature. | Journal of investigational allergology & clinical immunology 20060101 |
| Effect of proton pump inhibitors on hepatic regeneration. | European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20060101 |
| In vitro bactericidal activities of Japanese rice-fluid against Helicobacter pylori strains. | International journal of medical sciences 20060101 |
| The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey. | Acta haematologica 20060101 |
| Heartburn severity does not predict disease severity in patients with erosive esophagitis. | MedGenMed : Medscape general medicine 20060101 |
| Pharmacokinetic drug interaction profiles of proton pump inhibitors. | Drug safety 20060101 |
| Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A. | International journal of medical sciences 20060101 |
| Spontaneous intra-peritoneal bleeding secondary to warfarin, presenting as an acute appendicitis: a case report and review of literature. | BMC blood disorders 20060101 |
| Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. | BMC musculoskeletal disorders 20060101 |
| Acid regurgitation associated with persistent cough after pulmonary resection: an observational study. | Cough (London, England) 20060101 |
| Comparison of the effects of single and repeated oral doses of lansoprazole and rabeprazole on ambulatory 24-hour intragastric pH in healthy volunteers. | Clinical drug investigation 20060101 |
| Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma. | Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20060101 |
| Summarizing drug information in Medline citations. | AMIA ... Annual Symposium proceedings. AMIA Symposium 20060101 |
| Optimal maintenance therapy in patients with non-erosive reflux disease reporting mild reflux symptoms--a pilot study. | Advances in medical sciences 20060101 |
| Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. | World journal of gastroenterology 20051221 |
| Review article: similarities and differences among delayed-release proton-pump inhibitor formulations. | Alimentary pharmacology & therapeutics 20051201 |
| Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication. | Expert review of anti-infective therapy 20051201 |
| Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients. | Journal of gastroenterology and hepatology 20051201 |
| [Comparison of Helicobacter pylori eradication rate according to different PPI-based triple therapy--omeprazole, rabeprazole, esomeprazole and lansoprazole--]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20051201 |
| Gastroprotective activity of sesquiterpene derivatives from Fabiana imbricata. | Phytotherapy research : PTR 20051201 |
| Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study. | The American journal of gastroenterology 20051201 |
| [Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy]. | Nihon rinsho. Japanese journal of clinical medicine 20051201 |
| Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20051101 |
| Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. | Annals of hematology 20051101 |
| Gastroprotective and cytotoxic effect of dehydroabietic acid derivatives. | Pharmacological research 20051101 |
| Nasal pain disrupting sleep as a presenting symptom of extraesophageal acid reflux in children. | International journal of pediatric otorhinolaryngology 20051101 |
| Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics. | The Annals of pharmacotherapy 20051101 |
| A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101 |
| Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. | Journal of gastroenterology and hepatology 20051101 |
| Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. | The American journal of medicine 20051101 |
| 'Proton-pump inhibitor-first' strategy versus 'step-up' strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan. | Journal of gastroenterology 20051101 |
| Helicobacter pylori treatment. | Southern medical journal 20051101 |
| Effect of N-acetyl cysteine on Helicobacter pylori. | Southern medical journal 20051101 |
| [Guidelines in the management of H. pylori infection in Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [H. pylori motility analysis]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Cap polyposis and Helicobacter pylori]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Recent topics on important drugs for H. pylori eradication: Lansoprazole]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [H. pylori eradication package set (Lansap)]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Triple therapy for eradication of Helicobacter pylori in Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Adverse effects of Helicobacter pylori eradication and its prevention]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [PPI plus bismuth-based quintuple therapy]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Investigation about 3rd line eradication of H. pylori]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Helicobacter pylori eradication therapy for children]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| Split median nerve. A report of two cases. | Folia morphologica 20051101 |
| Comparative study of the enantioselective separation of several antiulcer drugs by high-performance liquid chromatography and supercritical fluid chromatography. | Journal of chromatography. A 20051014 |
| Gastroprotective effect of the Mapuche crude drug Araucaria araucana resin and its main constituents. | Journal of ethnopharmacology 20051003 |
| A decade-long sour-taste sensation successfully treated with a proton-pump inhibitor. | Journal of oral rehabilitation 20051001 |
| Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis. | Journal of clinical pharmacology 20051001 |
| Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage. | International journal of clinical practice 20051001 |
| Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg. | Alimentary pharmacology & therapeutics 20051001 |
| CagA status and Helicobacter pylori eradication among dyspeptic patients. | Gastroenterologia y hepatologia 20051001 |
| The Lanz endotracheal tube decreases tracheal injury in dogs. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20051001 |
| Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK. | Current medical research and opinion 20051001 |
| Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium. | European journal of pharmacology 20050920 |
| Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050901 |
| Management of symptoms in step-down therapy of gastroesophageal reflux disease. | Journal of gastroenterology and hepatology 20050901 |
| Determinants of non-response in Helicobacter pylori eradication trials. | Journal of gastroenterology and hepatology 20050901 |
| Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. | Chest 20050901 |
| Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. | Clinical therapeutics 20050901 |
| Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube. | International journal of pharmaceutics 20050811 |
| Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors. | Allergy 20050801 |
| Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. | Fundamental & clinical pharmacology 20050801 |
| Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. | The American journal of gastroenterology 20050801 |
| [The clinical strategy for the Barrett's esophagus]. | Nihon rinsho. Japanese journal of clinical medicine 20050801 |
| A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology. | Digestive diseases and sciences 20050801 |
| [The cause of failure of eradication treatment of Helicobacter pylori]. | Rinsho byori. The Japanese journal of clinical pathology 20050801 |
| Mechanisms of action of leptin in preventing gastric ulcer. | World journal of gastroenterology 20050721 |
| A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20050715 |
| Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. | World journal of gastroenterology 20050714 |
| Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. | American journal of physiology. Gastrointestinal and liver physiology 20050701 |
| Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701 |
| Dipyridamole bioavailability in subjects with reduced gastric acidity. | Journal of clinical pharmacology 20050701 |
| Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status. | Alimentary pharmacology & therapeutics 20050701 |
| Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine. | British journal of clinical pharmacology 20050701 |
| Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701 |
| Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients. | Pathology international 20050701 |
| Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. | The Laryngoscope 20050701 |
| Lansoprazole-associated collagenous colitis: a case report. | Zeitschrift fur Gastroenterologie 20050701 |
| Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry. | Digestive diseases and sciences 20050701 |
| Investigations on the thermal behavior of omeprazole and other sulfoxides. | Die Pharmazie 20050701 |
| Quality of gastric ulcer healing evaluated by endoscopic ultrasonography. | World journal of gastroenterology 20050614 |
| Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia? | Journal of tropical pediatrics 20050601 |
| Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes. | Chirality 20050601 |
| Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes. | Journal of clinical pharmacology 20050601 |
| Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura. | Pediatrics international : official journal of the Japan Pediatric Society 20050601 |
| CYP35: xenobiotically induced gene expression in the nematode Caenorhabditis elegans. | Archives of biochemistry and biophysics 20050601 |
| Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients. | Alimentary pharmacology & therapeutics 20050601 |
| Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine. | Alimentary pharmacology & therapeutics 20050601 |
| Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050601 |
| Proton pump inhibitors may reduce tumour resistance. | Expert opinion on pharmacotherapy 20050601 |
| A 61-year-old man with dyspepsia and weight loss. | PLoS medicine 20050601 |
| Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. | Drug metabolism and pharmacokinetics 20050601 |
| The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. | Research in social & administrative pharmacy : RSAP 20050601 |
| Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. | Alimentary pharmacology & therapeutics 20050515 |
| Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms? | Journal of the European Academy of Dermatology and Venereology : JEADV 20050501 |
| Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication. | Digestive diseases and sciences 20050501 |
| Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients. | Digestive diseases and sciences 20050501 |
| Rabeprazole controls GERD symptoms in a patient for whom treatment with lansoprazole failed: first report of 'cluster GERD.'. | Digestive diseases and sciences 20050501 |
| [Role of esophageal motility abnormalities in severe reflux esophagitis]. | Zhonghua nei ke za zhi 20050501 |
| Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers. | Xenobiotica; the fate of foreign compounds in biological systems 20050501 |
| The ameliorative effect of dates (Phoenix dactylifera L.) on ethanol-induced gastric ulcer in rats. | Journal of ethnopharmacology 20050426 |
| Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients. | World journal of gastroenterology 20050421 |
| [Distribution of Helicobacter pylori in stomach before and after the administration of Lansoprazole]. | Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20050418 |
| Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. | Arthritis and rheumatism 20050415 |
| [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office]. | MMW Fortschritte der Medizin 20050407 |
| Antimicrobial actions of benzimidazoles against oral streptococci. | Oral microbiology and immunology 20050401 |
| Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity. | Scandinavian journal of gastroenterology 20050401 |
| Lack of interaction between atazanavir and lansoprazole. | AIDS (London, England) 20050324 |
| First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens. | Alimentary pharmacology & therapeutics 20050315 |
| [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office]. | MMW Fortschritte der Medizin 20050303 |
| Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques. | Journal of medical microbiology 20050301 |
| Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. | European journal of clinical investigation 20050301 |
| Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease. | Journal of pediatric gastroenterology and nutrition 20050301 |
| Simultaneous herpetic and candidal esophagitis in an immunocompetent teenager. | Journal of pediatric gastroenterology and nutrition 20050301 |
| Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. | Virchows Archiv : an international journal of pathology 20050301 |
| Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes. | British journal of clinical pharmacology 20050301 |
| Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole. | Digestive diseases and sciences 20050301 |
| Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme. | Irish medical journal 20050301 |
| Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20050301 |
| Mild cognitive impairment in Parkinson's disease: the challenge and the promise. | Neuropsychiatric disease and treatment 20050301 |
| Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225 |
| The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. | European journal of pharmacology 20050221 |
| Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils. | World journal of gastroenterology 20050221 |
| Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial. | World journal of gastroenterology 20050221 |
| Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis. | Alimentary pharmacology & therapeutics 20050215 |
| Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19. | Alimentary pharmacology & therapeutics 20050215 |
| Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner. | Drug metabolism and disposition: the biological fate of chemicals 20050201 |
| Effects of the association of lansoprazole, clarithromycin and metronidazole for helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test. | Medical science monitor : international medical journal of experimental and clinical research 20050201 |
| The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. | Alimentary pharmacology & therapeutics 20050201 |
| Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003. | Helicobacter 20050201 |
| Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice. | The Journal of pharmacy and pharmacology 20050201 |
| Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease. | Expert review of pharmacoeconomics & outcomes research 20050201 |
| Effect of adsorbents on the absorption of lansoprazole with surfactant. | International journal of pharmaceutics 20050131 |
| Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma. | British journal of cancer 20050131 |
| Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. | Alimentary pharmacology & therapeutics 20050115 |
| Neuropathy associated with lansoprazole treatment. | Muscle & nerve 20050101 |
| Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. | The Annals of pharmacotherapy 20050101 |
| Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. | Journal of gastroenterology and hepatology 20050101 |
| Persistent cough following pulmonary resection: observational and empiric study of possible causes. | The Annals of thoracic surgery 20050101 |
| Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050101 |
| Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers. | European journal of gastroenterology & hepatology 20050101 |
| Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management. | European journal of gastroenterology & hepatology 20050101 |
| The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. | Health and quality of life outcomes 20050101 |
| Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature. | Journal of gastroenterology 20050101 |
| Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness. | Critical care (London, England) 20050101 |
| The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101 |
| [Proton pump inhibitors in paediatrics]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050101 |
| Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro. | Xenobiotica; the fate of foreign compounds in biological systems 20050101 |
| Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy. | Hepato-gastroenterology 20050101 |
| Why is this woman smiling? The hard sell of bad medicine. | Revolution (Oakland, Calif.) 20050101 |
| Pharmacokinetics of proton pump inhibitors in children. | Clinical pharmacokinetics 20050101 |
| Preventing the gastrointestinal consequences of stress-related mucosal disease. | Current medical research and opinion 20050101 |
| Idiopathic portal hypertension complicating systemic sclerosis: a case report. | BMC gastroenterology 20050101 |
| Gastroesophageal reflux disease in children with asthma: treatment implications. | Paediatric drugs 20050101 |
| Lansoprazole oro-dispersible tablet : pharmacokinetics and therapeutic use in acid-related disorders. | Drugs 20050101 |
| [Pharmacogenomical aspects of gastroesophageal reflux disease]. | Vestnik Rossiiskoi akademii meditsinskikh nauk 20050101 |
| Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial. | Arquivos de gastroenterologia 20050101 |
| Gastroprotective effect and cytotoxicity of natural and semisynthetic labdane diterpenes from Araucaria araucana resin. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20050101 |
| Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. | Arthritis research & therapy 20050101 |
| Haemorrhagic gastritis and bleeding following rofecoxib administration. | Clinical and experimental rheumatology 20050101 |
| Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases. | Acta dermato-venereologica 20050101 |
| Investigation of the possibility of human-beta defensin 2 (hBD2) as a molecular marker of gastric mucosal inflammation. | Hepato-gastroenterology 20050101 |
| Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescents. | Drugs 20050101 |
| Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease. | PharmacoEconomics 20050101 |
| Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis. | Inflammopharmacology 20050101 |
| Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country. | BMC gastroenterology 20050101 |
| What is potent acid inhibition, and how can it be achieved? | Drugs 20050101 |
| Clinical response (remission of symptoms) in erosive and non-erosive gastro-oesophageal reflux disease. | Drugs 20050101 |
| Potent gastric acid inhibition in Helicobacter pylori eradication. | Drugs 20050101 |
| Gastroesophageal reflux disease and extraesophageal disease. | Reviews in gastroenterological disorders 20050101 |
| Taste comparisons for lansoprazole strawberry-flavoured delayed-release orally disintegrating tablet and ranitidine peppermint-flavoured syrup in children. | Clinical drug investigation 20050101 |
| Proton pump inhibitors in acute treatment of reflux oesophagitis : a cost-effectiveness analysis. | Clinical drug investigation 20050101 |
| Review article: treatment for gastro-oesophageal reflux disease--lifestyle advice and medication. | Alimentary pharmacology & therapeutics 20041201 |
| Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsules. | Clinical therapeutics 20041201 |
| Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201 |
| Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes. | European journal of clinical pharmacology 20041101 |
| Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment. | Alimentary pharmacology & therapeutics 20041101 |
| Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders. | Alimentary pharmacology & therapeutics 20041101 |
| Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes. | Journal of clinical pharmacology 20041101 |
| Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection. | Scandinavian journal of gastroenterology 20041101 |
| Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. | Cancer science 20041101 |
| Fatal toxic epidermal necrolysis due to lansoprazole. | Clinical and experimental dermatology 20041101 |
| Patent expiration for lansoprazole. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101 |
| [Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20041101 |
| Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen. | Journal of gastroenterology 20041101 |
| Treatment of gastric hemorrhage by pulverized omeprazole and antacid--concomitant administration via a nasogastric tube. | International journal of clinical pharmacology and therapeutics 20041101 |
| [Choice of proton pump inhibitors--does it play any role?]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20041021 |
| Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis. | Alimentary pharmacology & therapeutics 20041015 |
| [Galactorrhea induced by lansoprazole]. | Atencion primaria 20041015 |
| Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. | World journal of gastroenterology 20041001 |
| Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. | European journal of clinical pharmacology 20041001 |
| On-demand PPI requirements in patients with endoscopy-negative GERD. | Journal of clinical gastroenterology 20041001 |
| The effect of Helicobacter pylori eradication on gastroesophageal reflux disease. | Journal of clinical gastroenterology 20041001 |
| Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection. | European journal of gastroenterology & hepatology 20041001 |
| Review article: gastric pH -- the most relevant predictor of benefit in reflux disease? | Alimentary pharmacology & therapeutics 20041001 |
| Effect of lansoprazole for an idiopathic thrombocytopenic purpura patient with Helicobacter pylori infection who did not respond to prednisolone treatment. | Clinical and laboratory haematology 20041001 |
| Genetic and transmission analysis of Helicobacter pylori strains within a family. | Emerging infectious diseases 20041001 |
| Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20041001 |
| Effect of water intake on pharmacokinetics of lansoprazole from fast disintegrating tablet in human subjects. | Drug metabolism and pharmacokinetics 20041001 |
| Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. | Journal of gastroenterology 20041001 |
| Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. | Clinical therapeutics 20041001 |
| Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. | Archives of internal medicine 20040927 |
| Determination of lansoprazole in pharmaceutical capsules by flow injection analysis using UV-detection. | Journal of pharmaceutical and biomedical analysis 20040921 |
| Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study. | Alimentary pharmacology & therapeutics 20040915 |
| Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor. | The American journal of medicine 20040906 |
| Gastroesophageal reflux disease: could intervention in childhood reduce the risk of later complications? | The American journal of medicine 20040906 |
| Management of acid-related disorders in patients with dysphagia. | The American journal of medicine 20040906 |
| CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori. | Clinical pharmacology and therapeutics 20040901 |
| Pachydermia is not diagnostic of active laryngopharyngeal reflux disease. | The Laryngoscope 20040901 |
| Serum cholinesterase inhibition by omeprazole and lansoprazole. | Die Pharmazie 20040901 |
| Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. | Scandinavian journal of gastroenterology 20040901 |
| Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. | Journal of gastroenterology 20040901 |
| Results of triple eradication therapy in Japanese children: a retrospective multicenter study. | Journal of gastroenterology 20040901 |
| A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube. | Alimentary pharmacology & therapeutics 20040815 |
| Pantoprazole treatment does not invoke anti-inflammatory properties in vivo. | International immunopharmacology 20040801 |
| Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. | Drug metabolism and disposition: the biological fate of chemicals 20040801 |
| Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. | Helicobacter 20040801 |
| Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial. | Alimentary pharmacology & therapeutics 20040801 |
| Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations. | The Journal of pharmacy and pharmacology 20040801 |
| Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040801 |
| Pharmacokinetics of lansoprazole in Chinese healthy subjects in relation to CYP2C19 genotypes. | Acta pharmacologica Sinica 20040801 |
| Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection. | The American journal of gastroenterology 20040801 |
| [Test of refractory gastroesophageal reflux disease]. | Nihon rinsho. Japanese journal of clinical medicine 20040801 |
| [Primary care for GEDR]. | Nihon rinsho. Japanese journal of clinical medicine 20040801 |
| [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist]. | Nihon rinsho. Japanese journal of clinical medicine 20040801 |
| [PPI: new strategies for GERD]. | Nihon rinsho. Japanese journal of clinical medicine 20040801 |
| Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography. | Journal of separation science 20040801 |
| Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection. | Wiener klinische Wochenschrift 20040731 |
| [Chronic upper abdominal pain without improvement after using proton pump inhibitors]. | Deutsche medizinische Wochenschrift (1946) 20040709 |
| Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20040701 |
| Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole. | Alimentary pharmacology & therapeutics 20040701 |
| CYP2C19 polymorphism and proton pump inhibitors. | Basic & clinical pharmacology & toxicology 20040701 |
| Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. | Alimentary pharmacology & therapeutics 20040701 |
| Helicobacter pylori eradication decreases blood neutrophil and monocyte counts. | Alimentary pharmacology & therapeutics 20040701 |
| Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20040701 |
| Wyeth found guilty of paying to boost use of a specific medicine. | BMJ (Clinical research ed.) 20040626 |
| [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?]. | Presse medicale (Paris, France : 1983) 20040619 |
| The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20040615 |
| Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040601 |
| Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. | The American journal of medicine 20040601 |
| Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. | Journal of gastroenterology and hepatology 20040601 |
| A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe. | Alimentary pharmacology & therapeutics 20040601 |
| Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. | World journal of gastroenterology 20040601 |
| Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication. | Helicobacter 20040601 |
| Colonic toxicity of administered drugs and chemicals. | The American journal of gastroenterology 20040601 |
| Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient. | Clinical and experimental nephrology 20040601 |
| The influence of pretreatment on cure rates of Helicobacter pylori eradication. | The Netherlands journal of medicine 20040601 |
| Evaluation of fast disintegrating lansoprazole tablet in human subjects. | Drug metabolism and pharmacokinetics 20040601 |
| Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040525 |
| Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole. | Alimentary pharmacology & therapeutics 20040515 |
| The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial. | Alimentary pharmacology & therapeutics 20040515 |
| Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism. | The Annals of pharmacotherapy 20040501 |
| Mucosal concentration of basic fibroblast growth factor in the healing process in human giant gastric ulcers. | Journal of gastroenterology and hepatology 20040501 |
| Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy. | Archives of surgery (Chicago, Ill. : 1960) 20040501 |
| [Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20040501 |
| Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate. | Xenobiotica; the fate of foreign compounds in biological systems 20040501 |
| Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. | Langenbeck's archives of surgery 20040401 |
| Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. | World journal of gastroenterology 20040401 |
| Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study. | Helicobacter 20040401 |
| Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. | The American journal of gastroenterology 20040401 |
| Helicobacter pylori eradication: efficacy of conventional therapy in India. | Tropical doctor 20040401 |
| [Curative and preventive treatment of NSAID-associated gastroduodenal ulcers]. | Gastroenterologie clinique et biologique 20040401 |
| Efficacy of a triple therapy for Helicobacter pylori eradication in a well-developed urban area in Brazil. | Sao Paulo medical journal = Revista paulista de medicina 20040304 |
| Determination of pravastatin in tablets by capillary electrophoresis. | Farmaco (Societa chimica italiana : 1989) 20040301 |
| Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA. | Biological & pharmaceutical bulletin 20040301 |
| Pharmacogenomics of proton pump inhibitors. | Pharmacogenomics 20040301 |
| [Myoclonic encephalopathy associated with proton pump inhibitors]. | Revue neurologique 20040301 |
| [Eradication effect of lansoprazole-based triple therapy against H. pylori]. | Nihon rinsho. Japanese journal of clinical medicine 20040301 |
| [Effect of proton pump inhibitors (PPIs) on wound healing of gastric mucosal cell injury]. | Nihon rinsho. Japanese journal of clinical medicine 20040301 |
| The choice of proton pump inhibitor: does it matter? | Basic & clinical pharmacology & toxicology 20040301 |
| Schatzki's ring: to cut or break an unresolved problem. | Digestive diseases and sciences 20040301 |
| The acidity index: a simple approach to the measurement of gastric acidity. | Alimentary pharmacology & therapeutics 20040215 |
| Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20040215 |
| Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. | Toxicology and applied pharmacology 20040215 |
| Review article: epidemiology and management of gastro-oesophageal reflux in children. | Alimentary pharmacology & therapeutics 20040201 |
| Cost-minimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040201 |
| Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice. | Journal of pediatric surgery 20040201 |
| Stress-related mucosal disease: risk factors and prophylactic therapy. | Clinical therapeutics 20040201 |
| Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase. | Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 20040101 |
| Managing gastro-oesophageal reflux disease in children. | Digestion 20040101 |
| Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040101 |
| Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000. | BMC gastroenterology 20040101 |
| Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years. | Paediatric drugs 20040101 |
| Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. | Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20040101 |
| Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring. | BMC medicine 20040101 |
| The anatomical variations of the palmar cutaneous branch of the median nerve in Chinese adults. | Journal of the Chinese Medical Association : JCMA 20040101 |
| Efficacy of esomeprazole in patients with acid-peptic disorders. | Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20040101 |
| Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. | Hepato-gastroenterology 20040101 |
| [Cross reactivity among proton pump inhibitors: does it exits?]. | Allergologia et immunopathologia 20040101 |
| Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. | European journal of gastroenterology & hepatology 20040101 |
| Clarithromycin, lansoprazole, and metronidazole eradicated Helicobacter pylori infection in chronic renal insufficiency. | ACP journal club 20040101 |
| An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole. | Hepato-gastroenterology 20040101 |
| Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard. | Arzneimittel-Forschung 20040101 |
| [Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report]. | Annali italiani di chirurgia 20040101 |
| [Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates]. | Mikrobiyoloji bulteni 20040101 |
| Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. | Critical care (London, England) 20040101 |
| Delayed-release lansoprazole plus naproxen. | Drugs 20040101 |
| Intravenous lansoprazole: in erosive oesophagitis. | Drugs 20040101 |
| Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study. | Hepato-gastroenterology 20040101 |
| Effectiveness of proton pump inhibitors: beyond cost. | Reviews in gastroenterological disorders 20040101 |
| Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux? | Digestive diseases and sciences 20040101 |
| [Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment]. | Revista de gastroenterologia de Mexico 20040101 |
| In vivo and in vitro research on the biological effects of deuterium-depleted water: 1. Influence of deuterium-depleted water on cultured cell growth. | Romanian journal of physiology : physiological sciences 20040101 |
| Esomeprazole 20mg provides more effective intragastric Acid control than maintenance-dose rabeprazole, lansoprazole or pantoprazole in healthy volunteers. | Clinical drug investigation 20040101 |
| Variability of the anteversion angle in children with Perthes' disease treated with varus-derotation subtrochanteric osteotomy. | Ortopedia, traumatologia, rehabilitacja 20040101 |
| A 100 kDa vanadate and lanzoprazole-sensitive ATPase from Streptococcus mutans membrane. | Archives of oral biology 20031201 |
| Secondary eradication of Helicobacter pylori was effective against refractory idiopathic thrombocytopenic purpura. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20031201 |
| Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole. | Alimentary pharmacology & therapeutics 20031201 |
| Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective. | Alimentary pharmacology & therapeutics 20031201 |
| Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole. | Journal of gastroenterology and hepatology 20031201 |
| Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. | The American journal of gastroenterology 20031201 |
| Effects of Helicobacter pylori infection on the link between regenerating gene expression and serum gastrin levels in Mongolian gerbils. | Laboratory investigation; a journal of technical methods and pathology 20031201 |
| Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice? | Scandinavian journal of gastroenterology 20031201 |
| In treatment of active duodenal ulcer and Helicobacter pylori eradication. | Hepato-gastroenterology 20031201 |
| Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. | British journal of cancer 20031117 |
| Immunoelectron microscopic study for histamine in the gastric enterochromaffin-like cells of rats treated with the proton pump inhibitor lansoprazole. | Histochemistry and cell biology 20031101 |
| Lansoprazole-induced hepatic dysfunction. | The Annals of pharmacotherapy 20031101 |
| Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. | The American journal of gastroenterology 20031101 |
| [The treatment of Helicobacter pylori infection in upper gastrointestinal disorders]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20031101 |
| ['Mirror, mirror on the wall which is the best proton pump inhibitor of all?']. | Zeitschrift fur Gastroenterologie 20031101 |
| Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial. | Alimentary pharmacology & therapeutics 20031015 |
| Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis. | Toxicology and applied pharmacology 20031015 |
| Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes. | Drug metabolism and disposition: the biological fate of chemicals 20031001 |
| Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets. | Chemical & pharmaceutical bulletin 20031001 |
| Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001 |
| Proton pump inhibitors in children: a review. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001 |
| One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection. | Archives of internal medicine 20030922 |
| Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. | Alimentary pharmacology & therapeutics 20030915 |
| Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. | Alimentary pharmacology & therapeutics 20030915 |
| Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20030915 |
| A case of mucosa-associated lymphoid tissue lymphoma of the ampulla of Vater: successful treatment with radiation therapy. | European journal of gastroenterology & hepatology 20030901 |
| Formulation study for lansoprazole fast-disintegrating tablet. II. Effect of triethyl citrate on the quality of the products. | Chemical & pharmaceutical bulletin 20030901 |
| Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. | The American journal of gastroenterology 20030901 |
| Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. | The American journal of gastroenterology 20030901 |
| Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease. | The Keio journal of medicine 20030901 |
| The impact of gastroesophageal reflux disease on quality of life. | Surgical endoscopy 20030801 |
| Formulation study for lansoprazole fast-disintegrating tablet. I. Effect of compression on dissolution behavior. | Chemical & pharmaceutical bulletin 20030801 |
| Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers. | World journal of gastroenterology 20030715 |
| Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. | Alimentary pharmacology & therapeutics 20030701 |
| Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030701 |
| [Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20030701 |
| A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis. | Clinical therapeutics 20030701 |
| Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20030701 |
| [All proton pump inhibitors are equally efficacious in standard dosages]. | Lakartidningen 20030619 |
| Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. | Alimentary pharmacology & therapeutics 20030615 |
| How can the current strategies for Helicobacter pylori eradication therapy be improved? | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030601 |
| [In-vitro activity of rabeprazole, lansoprazole, and esomeprazole against Helicobacter pylori]. | Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 20030601 |
| The effectiveness of omeprazole versus lansoprazole along with amoxicillin and clarithromycin in Turkish population with duodenal ulcer. | Minerva gastroenterologica e dietologica 20030601 |
| Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20030515 |
| The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency. | Alimentary pharmacology & therapeutics 20030515 |
| Structural and functional characterization of gastric mucosa and central nervous system in histamine H2 receptor-null mice. | European journal of pharmacology 20030502 |
| Diarrhea associated with lansoprazole. | Journal of gastroenterology and hepatology 20030501 |
| A cost-effectiveness analysis of stress ulcer prophylaxis. | The Annals of pharmacotherapy 20030501 |
| Lansoprazole overutilization: methods for step-down therapy. | The American journal of managed care 20030501 |
| The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux. | The Journal of laryngology and otology 20030501 |
| Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. | European journal of pharmacology 20030411 |
| The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism. | Alimentary pharmacology & therapeutics 20030401 |
| Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review. | Helicobacter 20030401 |
| Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori. | Helicobacter 20030401 |
| Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans. | Annals of surgery 20030401 |
| Pharmacogenetics of the proton pump inhibitors: a systematic review. | Pharmacotherapy 20030401 |
| Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode. | Journal of pharmaceutical and biomedical analysis 20030401 |
| A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole. | Alimentary pharmacology & therapeutics 20030401 |
| Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin. | Epidemiology and infection 20030401 |
| Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with beta-cyclodextrin. | Canadian journal of physiology and pharmacology 20030401 |
| Gastric myoelectrical activity in patients with recurrent gastric or duodenal ulcers. | Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20030401 |
| A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. | The Journal of biological chemistry 20030328 |
| Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20030315 |
| Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo. | Alimentary pharmacology & therapeutics 20030315 |
| Induction of cytochrome P450 enzymes in cultured precision-cut human liver slices. | Drug metabolism and disposition: the biological fate of chemicals 20030301 |
| Studies on hypertrophic effect of 90% partial pancreatectomy on the stomach in rats. | Pancreas 20030301 |
| Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors. | Biological & pharmaceutical bulletin 20030301 |
| Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. | British journal of haematology 20030301 |
| Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. | Chest 20030301 |
| Gastroesophageal reflux disease during pregnancy. | Gastroenterology clinics of North America 20030301 |
| The prophylactic use of a proton pump inhibitor before food and alcohol. | Alimentary pharmacology & therapeutics 20030301 |
| Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. | The American journal of gastroenterology 20030301 |
| [First line therapy for Helicobacter pylori eradication in France]. | Gastroenterologie clinique et biologique 20030301 |
| Synthesis or rupture: duration of acid inhibition by proton pump inhibitors. | Drugs of today (Barcelona, Spain : 1998) 20030301 |
| Review article: Esomeprazole--enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion. | Alimentary pharmacology & therapeutics 20030215 |
| Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. | Journal of gastroenterology and hepatology 20030201 |
| An aspirin a day keeps the cardiologist away (but what about the gastroenterologist?). | Gastroenterology 20030201 |
| Reflux disease and Barrett's esophagus. | Endoscopy 20030201 |
| Review of esomeprazole in the treatment of acid disorders. | Expert opinion on pharmacotherapy 20030201 |
| Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. | Alimentary pharmacology & therapeutics 20030201 |
| Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects. | Alimentary pharmacology & therapeutics 20030201 |
| Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. | Alimentary pharmacology & therapeutics 20030201 |
| Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. | The American journal of gastroenterology 20030201 |
| Review article: gastric acidity--comparison of esomeprazole with other proton pump inhibitors. | Alimentary pharmacology & therapeutics 20030201 |
| Review article: initial therapy of reflux disease with esomeprazole. | Alimentary pharmacology & therapeutics 20030201 |
| Review article: esomeprazole, 40 mg once daily, compared with lansoprazole, 30 mg once daily, in healing and symptom resolution of erosive oesophagitis. | Alimentary pharmacology & therapeutics 20030201 |
| Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. | Alimentary pharmacology & therapeutics 20030201 |
| Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics. | Xenobiotica; the fate of foreign compounds in biological systems 20030201 |
| Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori. | The journal of medical investigation : JMI 20030201 |
| [Guidelines in the management of Helicobacter pylori infection in Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure. | Singapore medical journal 20030201 |
| Lansoprazole quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030115 |
| A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. | The Biochemical journal 20030101 |
| Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. | Drugs 20030101 |
| Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients. | Alimentary pharmacology & therapeutics 20030101 |
| Safety and pharmacokinetics of oral lansoprazole in preadolescent rats exposed from weaning through sexual maturity. | Reproductive toxicology (Elmsford, N.Y.) 20030101 |
| Lansoprazole reduced recurrence of ulcer complications in long-term use of low-dose aspirin. | ACP journal club 20030101 |
| The use of proton pump inhibitors in children: a comprehensive review. | Paediatric drugs 20030101 |
| Lansoprazole: in the management of gastroesophageal reflux disease in children. | Paediatric drugs 20030101 |
| Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole. | Alimentary pharmacology & therapeutics 20030101 |
| Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. | Alimentary pharmacology & therapeutics 20030101 |
| Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. | European journal of gastroenterology & hepatology 20030101 |
| [New triple therapy for Helicobacter pylori infection in Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20030101 |
| [Tailor-made medicine in Helicobacter pylori eradication therapy]. | Nihon rinsho. Japanese journal of clinical medicine 20030101 |
| Utility and limitations of a method for detecting Helicobacter pylori-specific antigens in the stool. | Journal of gastroenterology 20030101 |
| Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor. | Digestion 20030101 |
| Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. | Journal of gastroenterology 20030101 |
| Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori. | Journal of gastroenterology 20030101 |
| Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy. | Hepato-gastroenterology 20030101 |
| Quadruple therapy for initial eradication of Helicobacter pylori in peptic ulcer: comparison with triple therapy. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20030101 |
| Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy. | Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20030101 |
| Compartment theory in Helicobacter pylori-associated gastric carcinogenesis. | Anticancer research 20030101 |
| Quality of life and cost-effectiveness of combined therapy for reflux esophagitis. | Journal of Zhejiang University. Science 20030101 |
| An unusual presentation of Castleman's disease:a case report. | BMC infectious diseases 20030101 |
| Impact of cotherapy with some proton pump inhibitors on medical claims among HMO patients already using other common drugs also cleared by cytochrome P450. | American journal of therapeutics 20030101 |
| Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro. | Journal of gastroenterology 20030101 |
| Improving health-related quality of life in gastro-oesophageal reflux disease. | Drugs 20030101 |
| COX-2 inhibition versus gastroprotection with dual COX inhibitors: an evidence-based approach. | Current pharmaceutical design 20030101 |
| [Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease]. | Klinicheskaia meditsina 20030101 |
| An overview of proton pump inhibitors. | Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20030101 |
| Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection. | Journal of gastroenterology 20030101 |
| Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know. | Drugs 20030101 |
| Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients. | Journal of gastroenterology 20030101 |
| Gastroesophageal reflux disease: current treatment approaches. | Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20030101 |
| Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics. | Journal of pediatric gastroenterology and nutrition 20030101 |
| Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers. | Digestion 20030101 |
| Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. | The Journal of pharmacology and experimental therapeutics 20021201 |
| The pharmacology and clinical relevance of proton pump inhibitors. | Current gastroenterology reports 20021201 |
| The effects of nocturnal acid breakthrough on Helicobacter pylori eradication. | Helicobacter 20021201 |
| Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication. | ANZ journal of surgery 20021201 |
| Facial swelling and eosinophilia in a 44-year-old woman. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20021201 |
| Low-dose aspirin: protection from the panacea. | The American journal of gastroenterology 20021201 |
| Characteristics of diarrhoea in 10,008 users of lansoprazole in daily practice: which co-factors contribute? | Pharmacoepidemiology and drug safety 20021201 |
| Lansoprazole ineffective for functional dyspepsia. | The Journal of family practice 20021201 |
| Transport through liquid membranes containing omeprazole and lansoprazole. | Indian journal of biochemistry & biophysics 20021201 |
| Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin. | The New England journal of medicine 20021114 |
| Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations. | Journal of pharmaceutical and biomedical analysis 20021107 |
| Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. | Alimentary pharmacology & therapeutics 20021101 |
| Restoration of acid secretion following treatment with proton pump inhibitors. | Gastroenterology 20021101 |
| Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration. | The Journal of antimicrobial chemotherapy 20021101 |
| Impairment of mycophenolate mofetil absorption by calcium polycarbophil. | Journal of clinical pharmacology 20021101 |
| Lansoprazole-associated microscopic colitis: a case series. | The American journal of gastroenterology 20021101 |
| Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation. | Transplantation proceedings 20021101 |
| [Helicobacter pylori induced gastritis: recent topics on eradication therapy]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20021101 |
| HTLV-I carrier status disclosed at diagnosis of cytomegalovirus gastric ulcer. | Leukemia & lymphoma 20021101 |
| Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro. | International journal of urology : official journal of the Japanese Urological Association 20021101 |
| Nonsteroidal antiinflammatory drugs and the stomach. | Current opinion in gastroenterology 20021101 |
| Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs. | Archives of internal medicine 20021028 |
| [In small steps to far ahead. Diminished risk of interactions as definite advantage]. | MMW Fortschritte der Medizin 20021010 |
| Asymmetries in H+/K+-ATPase and cell membrane potentials comprise a very early step in left-right patterning. | Cell 20021004 |
| Functional dyspepsia: bye-bye to PPIs. | Gut 20021001 |
| Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. | Gut 20021001 |
| Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers. | Alimentary pharmacology & therapeutics 20021001 |
| Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. | The American journal of gastroenterology 20021001 |
| Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. | Clinical pharmacology and therapeutics 20021001 |
| Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection. | Helicobacter 20021001 |
| A case of acute gastric mucosal lesions associated with Helicobacter heilmannii infection. | Helicobacter 20021001 |
| Medication errors. Liquid lansoprazole: gumming up the works. | Nursing 20021001 |
| [Anti-inflammatory non-steroidal selective cyclooxygenase 2 inhibitors and gastroduodenal lesions]. | Presse medicale (Paris, France : 1983) 20020928 |
| Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20020901 |
| Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case. | Diseases of the colon and rectum 20020901 |
| Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine. | The American journal of gastroenterology 20020901 |
| Motion--Helicobacter pylori worsens GERD: arguments for the motion. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020901 |
| Motion--Helicobacter pylori causes or worsens GERD: arguments against the motion. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020901 |
| Gateways to Clinical Trials. | Methods and findings in experimental and clinical pharmacology 20020901 |
| [Helicobacter pylori--overview of therapy]. | Lijecnicki vjesnik 20020901 |
| Does eradication of Helicobacter pylori infection reduce hypergastrinema during long term therapy with proton pump inhibitors? | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20020901 |
| Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence. | British journal of cancer 20020827 |
| Tetany secondary to the use of a proton-pump inhibitor. | Annals of internal medicine 20020806 |
| Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. | British journal of haematology 20020801 |
| Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin. | The Journal of antimicrobial chemotherapy 20020801 |
| Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures. | Helicobacter 20020801 |
| Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori. | Helicobacter 20020801 |
| One week regimen of esomeprazole based triple therapy is sufficient for duodenal ulcer healing and Helicobacter pylori eradication in patients with duodenal ulcer disease. | European journal of gastroenterology & hepatology 20020801 |
| [Reflux esophagitis]. | Nihon rinsho. Japanese journal of clinical medicine 20020801 |
| [Eradication therapy of Helicobacter pylori for elderly patients in Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20020801 |
| [Several points that should be noticed during PPI treatment for peptic ulcers in elderly patients]. | Nihon rinsho. Japanese journal of clinical medicine 20020801 |
| Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation. | Clinical therapeutics 20020801 |
| Proton pump inhibitors: an update. | American family physician 20020715 |
| Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype. | Journal of gastroenterology and hepatology 20020701 |
| [Eradication of helicobacter pylori: symptomatic treatment of reflux disease?]. | Zeitschrift fur Gastroenterologie 20020701 |
| An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy. | Alimentary pharmacology & therapeutics 20020701 |
| Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol. | Clinical pharmacology and therapeutics 20020701 |
| Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19. | Clinical pharmacology and therapeutics 20020701 |
| [Treatment of NSAID-associated gastric ulcer]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020701 |
| Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs. | Managed care (Langhorne, Pa.) 20020701 |
| Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. | The New England journal of medicine 20020627 |
| Pharmacologic management of gastroesophageal reflux disease. | Current gastroenterology reports 20020601 |
| Gastroprotective activity of the diterpene solidagenone and its derivatives on experimentally induced gastric lesions in mice. | Journal of ethnopharmacology 20020601 |
| Circumferential endoscopic mucosal resection in the swine esophagus assisted by a cap attachment. | Gastrointestinal endoscopy 20020601 |
| Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial. | Alimentary pharmacology & therapeutics 20020601 |
| Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. | Alimentary pharmacology & therapeutics 20020601 |
| Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. | Helicobacter 20020601 |
| Symptomatic ulceration of an acid-producing oesophageal inlet patch colonized by helicobacter pylori. | Endoscopy 20020601 |
| Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record -- Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy. | Medical science monitor : international medical journal of experimental and clinical research 20020601 |
| A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial. | European journal of gastroenterology & hepatology 20020601 |
| Protection against aspiration with the Proseal laryngeal mask airway. | Anaesthesia and intensive care 20020601 |
| Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis. | The American journal of gastroenterology 20020601 |
| Osteoporosis with underlying connective tissue disease: an unusual case. | Annals of the New York Academy of Sciences 20020601 |
| On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole. | Scandinavian journal of gastroenterology 20020601 |
| Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection. | Internal medicine (Tokyo, Japan) 20020601 |
| Gateways to Clinical Trials. June 2002. | Methods and findings in experimental and clinical pharmacology 20020601 |
| Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression. | Alimentary pharmacology & therapeutics 20020501 |
| Lansoprazole-induced thrombocytopenia. | The Annals of pharmacotherapy 20020501 |
| Combination drug therapy for gastroesophageal reflux disease. | The Annals of pharmacotherapy 20020501 |
| Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. | Clinical pharmacology and therapeutics 20020501 |
| Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with lansoprazole and Nissen fundoplication: a case report. | Gastrointestinal endoscopy 20020401 |
| Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups. | Alimentary pharmacology & therapeutics 20020401 |
| Patient perceptions of a proton pump inhibitor therapeutic interchange program across the continuum of care. | Pharmacotherapy 20020401 |
| Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori. | Alimentary pharmacology & therapeutics 20020401 |
| Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection. | Helicobacter 20020401 |
| Does reduction in gastric acid secretion in bariatric surgery increase diet-induced thermogenesis? | Obesity surgery 20020401 |
| Effect of hypergastrinemia on pancreatic carcinogenesis. | American journal of surgery 20020401 |
| Is lansoprazole (Prevacid) or omeprazole (Prilosec) more effective in treating erosive esophagitis? | The Journal of family practice 20020401 |
| Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice. | The Journal of pharmacy and pharmacology 20020401 |
| Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome. | Gastroenterologie clinique et biologique 20020401 |
| [Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20020320 |
| Review article: rabeprazole-based therapy in Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20020301 |
| Acid suppression in healthy subjects following lansoprazole or pantoprazole. | Alimentary pharmacology & therapeutics 20020301 |
| The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. | Alimentary pharmacology & therapeutics 20020301 |
| Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20020301 |
| Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test. | Alimentary pharmacology & therapeutics 20020301 |
| A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat. | Clinical and experimental pharmacology & physiology 20020301 |
| Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. | The American journal of gastroenterology 20020301 |
| Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. | The American journal of gastroenterology 20020301 |
| An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole. | International journal of clinical practice 20020301 |
| Failure of Helicobacter pylori eradication: is poor compliance the main cause? | Gastroenterologie clinique et biologique 20020301 |
| Legionellosis in a lung transplant recipient obscured by cytomegalovirus infection and Clostridium difficile colitis. | Transplant infectious disease : an official journal of the Transplantation Society 20020301 |
| Collagenous colitis associated with lansoprazole. | Journal of clinical gastroenterology 20020201 |
| Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up. | British journal of clinical pharmacology 20020201 |
| Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies. | Alimentary pharmacology & therapeutics 20020201 |
| Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors. | Alimentary pharmacology & therapeutics 20020201 |
| In support of 'step-up therapy' for gastroesophageal reflux disease. | The American journal of gastroenterology 20020201 |
| Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication. | Helicobacter 20020201 |
| [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20020201 |
| Proton pump inhibitors or surgery for gastro-oesophageal reflux disease. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020201 |
| Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020201 |
| [The outline of medical treatment of peptic ulcer]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Guidelines for the management of Helicobacter pylori infection in Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [New triple therapy for Helicobacter pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Adverse effects of H. pylori eradication therapy and its measure]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [H. pylori eradication therapy and natural history of peptic ulcer]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Treatment of NSAIDs induced ulcers]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Intractable ulcer]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Gastroduodenal ulcer in childhood]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Peptic ulcer in the elderly]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Plaunotol]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Ecabet sodium]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Polaprezinc]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Cause and prevention of nocturnal gastric acid breakthrough]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Helicobacter heilmannii-associated gastritis]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| Conformational analysis: a new approach by means of chemometrics. | Journal of computational chemistry 20020130 |
| Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). | Archives of internal medicine 20020128 |
| Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. | Archives of internal medicine 20020128 |
| Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. | Transplantation 20020127 |
| Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa. | The New England journal of medicine 20020110 |
| [Progress of tailor-made treatment of peptic ulcer]. | Nihon rinsho. Japanese journal of clinical medicine 20020101 |
| Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. | International journal of antimicrobial agents 20020101 |
| Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. | The Journal of dermatology 20020101 |
| Acute manic psychosis induced by triple therapy for H. pylori. | The Journal of the American Board of Family Practice 20020101 |
| Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison. | Alimentary pharmacology & therapeutics 20020101 |
| Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20020101 |
| Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis. | Alimentary pharmacology & therapeutics 20020101 |
| Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101 |
| Gastric adenocarcinoma in a patient re-infected with H. pylori after regression of MALT lymphoma with successful anti-H. pylori therapy and gastric resection: a case report. | BMC gastroenterology 20020101 |
| Dual versus triple therapy in eradication of Helicobacter pylori. | Hepato-gastroenterology 20020101 |
| One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy. | Journal of clinical gastroenterology 20020101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20020101 |
| Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis. | ACP journal club 20020101 |
| Esomeprazole: a review of its use in the management of acid-related disorders in the US. | Drugs 20020101 |
| Determinants of headache in lansoprazole users in The Netherlands: results from a nested case-control study. | Drug safety 20020101 |
| Lansoprazole for maintenance of remission of erosive oesophagitis. | Drugs 20020101 |
| Histological and clinical predictive value of determination of tissue CagA status by PCR in Helicobacter pylori infected patients; results of the large population based study in western Turkey. | Hepato-gastroenterology 20020101 |
| Esomeprazole: a review of its use in the management of acid-related disorders. | Drugs 20020101 |
| Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study. | American journal of therapeutics 20020101 |
| Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials. | BMC gastroenterology 20020101 |
| Gastroesophageal reflux disease: new treatments. | Reviews in gastroenterological disorders 20020101 |
| [Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers]. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20020101 |
| [Reactive polyarthritis and painful dermatographism caused by Helicobacter pylori]. | Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20020101 |
| Clinical significance of the cytochrome P450 2C19 genetic polymorphism. | Clinical pharmacokinetics 20020101 |
| Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers. | The Journal of international medical research 20020101 |
| Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment. | Paediatric drugs 20020101 |
| [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ]. | Klinicheskaia meditsina 20020101 |
| Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease. | Therapie 20020101 |
| The clinical importance of proton pump inhibitor pharmacokinetics. | Digestion 20020101 |
| [Microcirculation in gastric mucosa as related to its secretory activity in patients with peptic ulcer]. | Likars'ka sprava 20020101 |
| Anaphylaxis to proton pump inhibitors. | Allergologia et immunopathologia 20020101 |
| Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors. | Drugs & aging 20020101 |
| ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells. | Anticancer research 20020101 |
| Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children. | Journal of pediatric gastroenterology and nutrition 20020101 |
| Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children. | Journal of pediatric gastroenterology and nutrition 20020101 |
| Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease. | Journal of pediatric gastroenterology and nutrition 20020101 |
| Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability. | Journal of pediatric gastroenterology and nutrition 20020101 |
| Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin. | The Journal of antimicrobial chemotherapy 20011201 |
| Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. | European journal of gastroenterology & hepatology 20011201 |
| Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein. | Naunyn-Schmiedeberg's archives of pharmacology 20011201 |
| Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. | The American journal of gastroenterology 20011201 |
| Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011201 |
| [Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20011201 |
| Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes. | European journal of clinical pharmacology 20011201 |
| A systematic gene expression screen of Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic inducible. | Archives of biochemistry and biophysics 20011115 |
| The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20011101 |
| Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis. | Alimentary pharmacology & therapeutics 20011101 |
| Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan. | Alimentary pharmacology & therapeutics 20011101 |
| Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study. | Alimentary pharmacology & therapeutics 20011101 |
| A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH. | Alimentary pharmacology & therapeutics 20011101 |
| Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa. | Alimentary pharmacology & therapeutics 20011101 |
| Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication. | European journal of gastroenterology & hepatology 20011101 |
| Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine. | Digestive diseases and sciences 20011101 |
| Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19. | Clinical pharmacology and therapeutics 20011101 |
| Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients. | The American journal of gastroenterology 20011101 |
| Fine-needle aspiration biopsy of an intra-abdominal inflammatory mass secondary to a penetrating duodenal ulcer mimicking neoplasm. | Diagnostic cytopathology 20011101 |
| Pill-induced esophagitis caused by lansoprazole. | Journal of gastroenterology 20011101 |
| Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD). | The Laryngoscope 20011101 |
| [Lansoprazole-associated collagenous colitis]. | Gastroenterologie clinique et biologique 20011101 |
| Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers. | Journal of gastroenterology and hepatology 20011101 |
| Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux. | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20011001 |
| Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011001 |
| What is the best pharmacologic approach to managing moderate to severe heartburn? | The Journal of family practice 20011001 |
| Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy. | Digestive diseases and sciences 20011001 |
| A bioavailability/bioequivalence study of two oral lansoprazole formulations after single administration to healthy volunteers. | Die Pharmazie 20011001 |
| [Laryngeal manifestations of gastroesophageal reflux disease (GERD) in pediatric patients: the usefulness of therapeutic (proton pump inhibitor (PPI)) trials]. | Nihon Jibiinkoka Gakkai kaiho 20011001 |
| Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses. | Expert opinion on pharmacotherapy 20011001 |
| Proton pump inhibition. An effective, safe approach to GERD management. | Postgraduate medicine 20011001 |
| Noninvasive Helicobacter pylori testing for the 'test-and-treat' strategy: a decision analysis to assess the effect of past infection on test choice. | Archives of internal medicine 20010924 |
| Clinical and ethical concerns about switching patient treatment to 'therapeutically interchangeable' medications. | Archives of internal medicine 20010924 |
| [Comparative study of proton pump inhibitors]. | Orvosi hetilap 20010909 |
| Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms? | Journal of clinical gastroenterology 20010901 |
| Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. | Gut 20010901 |
| Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. | Alimentary pharmacology & therapeutics 20010901 |
| Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis. | Alimentary pharmacology & therapeutics 20010901 |
| Review article: long-term use of proton pump inhibitors in GORD--help or hindrance? | Alimentary pharmacology & therapeutics 20010901 |
| Review article: tackling the 'dyspeptic problem'. | Alimentary pharmacology & therapeutics 20010901 |
| Review article: managing the dyspeptic patient--an interactive discussion. | Alimentary pharmacology & therapeutics 20010901 |
| Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients. | Journal of pediatric gastroenterology and nutrition 20010901 |
| Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency? | Journal of pediatric gastroenterology and nutrition 20010901 |
| Guidelines in the management of Helicobacter pylori infection in Japan. | Helicobacter 20010901 |
| A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. | Helicobacter 20010901 |
| Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism. | European journal of clinical pharmacology 20010901 |
| [Complementary observational study of the efficacy, tolerance and safety of lansoprazole 15 mg as maintenance therapy of reflux esophagitis in daily medical practice in Belgium (record RU49749/R002]. | Revue medicale de Liege 20010901 |
| Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010815 |
| Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen. | Alimentary pharmacology & therapeutics 20010801 |
| High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. | Scandinavian journal of gastroenterology 20010801 |
| Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. | The American journal of gastroenterology 20010801 |
| [Administration of proton pump inhibitor caused esophageal stenosis in two patients with severe reflux esophagitis]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20010801 |
| Key topics in Helicobacter pylori eradication in the management of the dyspeptic patient: a panel discussion. | European journal of gastroenterology & hepatology 20010801 |
| Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit. | European journal of gastroenterology & hepatology 20010801 |
| Cost-effectiveness of proton-pump inhibitors for maintenance therapy of erosive reflux esophagitis. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010715 |
| Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. | Alimentary pharmacology & therapeutics 20010701 |
| Quadruple therapy for symptomatic spontaneous duodenal ulcer disease. | Postgraduate medical journal 20010701 |
| Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori. | Gastrointestinal endoscopy 20010701 |
| Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously. | The American journal of gastroenterology 20010701 |
| Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms. | Digestive diseases and sciences 20010701 |
| Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy. | Hospital medicine (London, England : 1998) 20010701 |
| Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. | Clinical therapeutics 20010701 |
| Efficacy of a nitroimidazole containing tripletherapy regime in Singapore. | Singapore medical journal 20010701 |
| High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes. | Journal of chromatography. B, Biomedical sciences and applications 20010605 |
| Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. | Lancet (London, England) 20010602 |
| Proton pump inhibitors: a study of GPs' prescribing. | Family practice 20010601 |
| Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans. | Microscopy research and technique 20010601 |
| Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes. | Alimentary pharmacology & therapeutics 20010601 |
| Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study. | Alimentary pharmacology & therapeutics 20010601 |
| Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. | Best practice & research. Clinical gastroenterology 20010601 |
| Laryngopharyngeal reflux symptoms improve before changes in physical findings. | The Laryngoscope 20010601 |
| Treatment of gastroesophageal reflux disease: to step or not to step. | The American journal of gastroenterology 20010601 |
| Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies. | The American journal of gastroenterology 20010601 |
| Discoloured tongue: a new cause? | The British journal of dermatology 20010601 |
| Helicobacter pylori and early duodenal ulcer status post-treatment: a review. | Helicobacter 20010601 |
| Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori. | Helicobacter 20010601 |
| Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection. | Journal of gastroenterology and hepatology 20010601 |
| Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given? | Scandinavian journal of gastroenterology 20010601 |
| Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor. | Medical mycology 20010601 |
| Factors associated with non-response in proton pump inhibitor users: a study of lansoprazole therapy. | Pharmacy world & science : PWS 20010601 |
| CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects. | Pharmaceutical research 20010601 |
| [Bifid median nerve in the carpal tunnel: integrated imaging]. | La Radiologia medica 20010601 |
| Follow-up of Helicobacter pylori status by using 13C-urea breath test in nonulcer dyspeptic patients after eradication therapy. | Zhonghua yi xue za zhi = Chinese medical journal; Free China ed 20010601 |
| Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. | Alimentary pharmacology & therapeutics 20010501 |
| Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases. | Digestive diseases and sciences 20010501 |
| Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract. | Inflammatory bowel diseases 20010501 |
| Insulinoma with subsequent association of Zollinger-Ellison syndrome. | Internal medicine (Tokyo, Japan) 20010501 |
| Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. | Clinical therapeutics 20010501 |
| Proton pump inhibitors and their drug interactions: an evidence-based approach. | European journal of gastroenterology & hepatology 20010501 |
| Lansoprazole triple therapy for Turkish children with Helicobacter pylori infections. | Journal of pediatric gastroenterology and nutrition 20010501 |
| Shortcomings of the first-generation proton pump inhibitors. | European journal of gastroenterology & hepatology 20010501 |
| New-generation proton pump inhibitors: overcoming the limitations of early-generation agents. | European journal of gastroenterology & hepatology 20010501 |
| [H2 receptor antagonists and proton pump inhibitors: principles and rules of use]. | La Revue du praticien 20010415 |
| Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue. | The Journal of antimicrobial chemotherapy 20010401 |
| Maximal acid reflux control for Barrett's oesophagus: feasible and effective. | Alimentary pharmacology & therapeutics 20010401 |
| Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor. | The American journal of gastroenterology 20010401 |
| Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. | The American journal of gastroenterology 20010401 |
| Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20010401 |
| [Gynecomastia associated with the simultaneous use of cisapride and lansoprazole]. | Medicina clinica 20010324 |
| Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. | Life sciences 20010309 |
| Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. | Annals of internal medicine 20010306 |
| Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. | Gut 20010301 |
| Bioequivalence evaluation of lansoprazole 30-mg capsules (Lanfast and Lanzor) in healthy volunteers. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20010301 |
| A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication. | Gastrointestinal endoscopy 20010301 |
| Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. | Clinical pharmacology and therapeutics 20010301 |
| Pharmacokinetic differences between lansoprazole enantiomers and contribution of cytochrome P450 isoforms to enantioselective metabolism of lansoprazole in dogs. | Biological & pharmaceutical bulletin 20010301 |
| Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model. | Journal of clinical pharmacology 20010301 |
| Electrochemical studies and differential pulse polarographic analysis of lansoprazole in pharmaceuticals. | The Analyst 20010301 |
| Acetaldehyde production and other ADH-related characteristics of aerobic bacteria isolated from hypochlorhydric human stomach. | Alcoholism, clinical and experimental research 20010301 |
| The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. | The Israel Medical Association journal : IMAJ 20010301 |
| Gastroprotective effect of aparisthman, a diterpene isolated from Aparisthmium cordatum, on experimental gastric ulcer models in rats and mice. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20010301 |
| Pantoprazole versus lansoprazole in French patients with reflux esophagitis. | Gastroenterologie clinique et biologique 20010301 |
| Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection. | FEBS letters 20010202 |
| Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. | Alimentary pharmacology & therapeutics 20010201 |
| Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis. | Alimentary pharmacology & therapeutics 20010201 |
| [Recent guidelines for the management of Helicobacter pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20010201 |
| [Usefulness of new triple therapy containing PPI]. | Nihon rinsho. Japanese journal of clinical medicine 20010201 |
| [A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment]. | Nihon rinsho. Japanese journal of clinical medicine 20010201 |
| Aggressive acid control: minimizing progression of Barrett's esophagus. | The American journal of managed care 20010201 |
| Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. | Journal of gastroenterology 20010201 |
| Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? | The American journal of gastroenterology 20010201 |
| [Suppressive effect of lansoprazole on anti-Candida activity of murine macrophages]. | Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20010201 |
| Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. | The American journal of medicine 20010108 |
| Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. | Alimentary pharmacology & therapeutics 20010101 |
| Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers. | Alimentary pharmacology & therapeutics 20010101 |
| Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer. | Journal of clinical gastroenterology 20010101 |
| Allergic contact dermatitis due to lansoprazole, a proton pump inhibitor. | Contact dermatitis 20010101 |
| Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis. | Pediatric pulmonology 20010101 |
| Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis. | Arthritis research 20010101 |
| Drug interaction: omeprazole and phenprocoumon. | BMC gastroenterology 20010101 |
| Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer. | Revista do Hospital das Clinicas 20010101 |
| Effects of lansoprazole on human gastric lipase secretion and intragastric lipolysis in healthy human volunteers. | Digestion 20010101 |
| [The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis]. | Klinicheskaia meditsina 20010101 |
| Efficacy of Helicobacter pylori eradication therapies: a single centre observational study. | BMC gastroenterology 20010101 |
| A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. | Digestive diseases (Basel, Switzerland) 20010101 |
| Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy. | Digestive diseases (Basel, Switzerland) 20010101 |
| Advantage of expressing the variations in some digestive parameters as a function of gastric emptying instead of time. | Digestion 20010101 |
| The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study. | Managed care interface 20010101 |
| Gastroesophageal reflux disease presenting as xerophthalmia. | Journal of pediatric ophthalmology and strabismus 20010101 |
| Six regimens for the eradication of Helicobacter pylori (Hp) in duodenal ulcer patients: three consecutive trials (1995-1999). | Journal of physiology, Paris 20010101 |
| Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101 |
| Lansoprazole: an update of its place in the management of acid-related disorders. | Drugs 20010101 |
| Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality. | Scandinavian journal of gastroenterology. Supplement 20010101 |
| A practice-based approach for converting from proton pump inhibitors to less costly therapy. | Effective clinical practice : ECP 20010101 |
| Rabeprazole: an update of its use in acid-related disorders. | Drugs 20010101 |
| Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin. | Acta medica (Hradec Kralove) 20010101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.